KR20120043191A - Novel enol phosphate derivatives and their preparation method from alkynes catalyzed by gold - Google Patents
Novel enol phosphate derivatives and their preparation method from alkynes catalyzed by gold Download PDFInfo
- Publication number
- KR20120043191A KR20120043191A KR1020100104367A KR20100104367A KR20120043191A KR 20120043191 A KR20120043191 A KR 20120043191A KR 1020100104367 A KR1020100104367 A KR 1020100104367A KR 20100104367 A KR20100104367 A KR 20100104367A KR 20120043191 A KR20120043191 A KR 20120043191A
- Authority
- KR
- South Korea
- Prior art keywords
- alkyl
- aryl
- mmol
- formula
- aucl
- Prior art date
Links
- -1 enol phosphate derivatives Chemical class 0.000 title claims abstract description 114
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 title claims abstract description 33
- 229910052737 gold Inorganic materials 0.000 title claims abstract description 33
- 239000010931 gold Substances 0.000 title claims abstract description 33
- 238000002360 preparation method Methods 0.000 title claims description 45
- 150000001345 alkine derivatives Chemical class 0.000 title 1
- 239000003054 catalyst Substances 0.000 claims abstract description 44
- 229910003771 Gold(I) chloride Inorganic materials 0.000 claims abstract description 42
- FDWREHZXQUYJFJ-UHFFFAOYSA-M gold monochloride Chemical compound [Cl-].[Au+] FDWREHZXQUYJFJ-UHFFFAOYSA-M 0.000 claims abstract description 42
- 238000000034 method Methods 0.000 claims abstract description 27
- 150000001335 aliphatic alkanes Chemical class 0.000 claims abstract description 14
- 239000000126 substance Substances 0.000 claims abstract description 8
- JCYWCSGERIELPG-UHFFFAOYSA-N imes Chemical compound CC1=CC(C)=CC(C)=C1N1C=CN(C=2C(=CC(C)=CC=2C)C)[C]1 JCYWCSGERIELPG-UHFFFAOYSA-N 0.000 claims abstract description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 117
- 238000006243 chemical reaction Methods 0.000 claims description 41
- 239000002904 solvent Substances 0.000 claims description 39
- 125000006736 (C6-C20) aryl group Chemical group 0.000 claims description 24
- 125000006701 (C1-C7) alkyl group Chemical group 0.000 claims description 22
- 229910019142 PO4 Inorganic materials 0.000 claims description 22
- 239000010452 phosphate Substances 0.000 claims description 22
- 238000004519 manufacturing process Methods 0.000 claims description 13
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 12
- 229910052739 hydrogen Inorganic materials 0.000 claims description 12
- 239000001257 hydrogen Substances 0.000 claims description 12
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 10
- QRUBYZBWAOOHSV-UHFFFAOYSA-M silver trifluoromethanesulfonate Chemical compound [Ag+].[O-]S(=O)(=O)C(F)(F)F QRUBYZBWAOOHSV-UHFFFAOYSA-M 0.000 claims description 9
- 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 claims description 8
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 8
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 8
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims description 8
- 125000003545 alkoxy group Chemical group 0.000 claims description 8
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 8
- 125000005110 aryl thio group Chemical group 0.000 claims description 8
- 229910052709 silver Inorganic materials 0.000 claims description 8
- 239000004332 silver Substances 0.000 claims description 8
- 150000003013 phosphoric acid derivatives Chemical class 0.000 claims description 7
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-dimethylformamide Substances CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 6
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 6
- 125000000217 alkyl group Chemical group 0.000 claims description 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 5
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 claims description 4
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 claims description 4
- 125000005196 alkyl carbonyloxy group Chemical group 0.000 claims description 4
- 125000004414 alkyl thio group Chemical group 0.000 claims description 4
- 125000003118 aryl group Chemical group 0.000 claims description 4
- 125000004104 aryloxy group Chemical group 0.000 claims description 4
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 4
- 125000002603 chloroethyl group Chemical group [H]C([*])([H])C([H])([H])Cl 0.000 claims description 4
- 125000000068 chlorophenyl group Chemical group 0.000 claims description 4
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 4
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 4
- 150000002431 hydrogen Chemical class 0.000 claims description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 4
- 101710134784 Agnoprotein Proteins 0.000 claims description 3
- LYGJENNIWJXYER-UHFFFAOYSA-N nitromethane Chemical compound C[N+]([O-])=O LYGJENNIWJXYER-UHFFFAOYSA-N 0.000 claims description 3
- 125000004209 (C1-C8) alkyl group Chemical group 0.000 claims description 2
- 125000005997 bromomethyl group Chemical group 0.000 claims description 2
- 125000004218 chloromethyl group Chemical group [H]C([H])(Cl)* 0.000 claims description 2
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims description 2
- 125000004210 cyclohexylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 claims description 2
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 claims description 2
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 claims description 2
- 125000000286 phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 claims description 2
- 125000004344 phenylpropyl group Chemical group 0.000 claims description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims 4
- 150000001408 amides Chemical class 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 238000003786 synthesis reaction Methods 0.000 abstract description 6
- 230000015572 biosynthetic process Effects 0.000 abstract description 5
- 229930014626 natural product Natural products 0.000 abstract description 3
- 125000002467 phosphate group Chemical class [H]OP(=O)(O[H])O[*] 0.000 abstract description 2
- 239000011149 active material Substances 0.000 abstract 1
- ASMQGLCHMVWBQR-UHFFFAOYSA-M diphenyl phosphate Chemical compound C=1C=CC=CC=1OP(=O)([O-])OC1=CC=CC=C1 ASMQGLCHMVWBQR-UHFFFAOYSA-M 0.000 description 36
- 238000004440 column chromatography Methods 0.000 description 33
- 150000001875 compounds Chemical class 0.000 description 28
- 238000003756 stirring Methods 0.000 description 27
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 7
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- HVAMZGADVCBITI-UHFFFAOYSA-M pent-4-enoate Chemical compound [O-]C(=O)CCC=C HVAMZGADVCBITI-UHFFFAOYSA-M 0.000 description 6
- 239000000543 intermediate Substances 0.000 description 4
- VBXZRQNADNSWSO-UHFFFAOYSA-N P(=O)(OC(=CC1=CC=CC=C1)C)(OC1=CC=CC=C1)OC1=CC=CC=C1 Chemical compound P(=O)(OC(=CC1=CC=CC=C1)C)(OC1=CC=CC=C1)OC1=CC=CC=C1 VBXZRQNADNSWSO-UHFFFAOYSA-N 0.000 description 3
- CZRMIMVRGWOUDV-UHFFFAOYSA-N P(=O)(OC=CC1=C(C=CC=C1)Cl)(OC1=CC=CC=C1)OC1=CC=CC=C1 Chemical compound P(=O)(OC=CC1=C(C=CC=C1)Cl)(OC1=CC=CC=C1)OC1=CC=CC=C1 CZRMIMVRGWOUDV-UHFFFAOYSA-N 0.000 description 3
- DGLHLIWXYSGYBI-UHFFFAOYSA-N 1-chloro-2-ethynylbenzene Chemical compound ClC1=CC=CC=C1C#C DGLHLIWXYSGYBI-UHFFFAOYSA-N 0.000 description 2
- XAOWCOIHCMCFSB-UHFFFAOYSA-N 3-bromoprop-1-en-2-yl diphenyl phosphate Chemical compound C=1C=CC=CC=1OP(=O)(OC(=C)CBr)OC1=CC=CC=C1 XAOWCOIHCMCFSB-UHFFFAOYSA-N 0.000 description 2
- AYMVDPOFEJOMLE-UHFFFAOYSA-N 5-chloropent-2-en-2-yl diphenyl phosphate Chemical compound C=1C=CC=CC=1OP(=O)(OC(C)=CCCCl)OC1=CC=CC=C1 AYMVDPOFEJOMLE-UHFFFAOYSA-N 0.000 description 2
- VEHUYSSXMGJTKV-UHFFFAOYSA-N 5-cyanopent-1-en-2-yl diphenyl phosphate Chemical compound P(=O)(OC(=C)CCCC#N)(OC1=CC=CC=C1)OC1=CC=CC=C1 VEHUYSSXMGJTKV-UHFFFAOYSA-N 0.000 description 2
- UEXCJVNBTNXOEH-UHFFFAOYSA-N Ethynylbenzene Chemical group C#CC1=CC=CC=C1 UEXCJVNBTNXOEH-UHFFFAOYSA-N 0.000 description 2
- FPOSPYFBFINMSC-UHFFFAOYSA-N P(=O)(OC(=C)CC1=CC=CC=C1)(OC1=CC=CC=C1)OC1=CC=CC=C1 Chemical compound P(=O)(OC(=C)CC1=CC=CC=C1)(OC1=CC=CC=C1)OC1=CC=CC=C1 FPOSPYFBFINMSC-UHFFFAOYSA-N 0.000 description 2
- 238000007259 addition reaction Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- NLHNDXICSCRJBV-UHFFFAOYSA-N diphenyl 1-phenylethenyl phosphate Chemical compound C=1C=CC=CC=1C(=C)OP(=O)(OC=1C=CC=CC=1)OC1=CC=CC=C1 NLHNDXICSCRJBV-UHFFFAOYSA-N 0.000 description 2
- 150000002085 enols Chemical class 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- FHDMXFPRTWCQQJ-UHFFFAOYSA-N oct-1-ynylsulfanylbenzene Chemical compound CCCCCCC#CSC1=CC=CC=C1 FHDMXFPRTWCQQJ-UHFFFAOYSA-N 0.000 description 2
- RIZZXCJMFIGMON-UHFFFAOYSA-N prop-2-ynyl acetate Chemical compound CC(=O)OCC#C RIZZXCJMFIGMON-UHFFFAOYSA-N 0.000 description 2
- NGKSKVYWPINGLI-UHFFFAOYSA-N prop-2-ynylbenzene Chemical compound C#CCC1=CC=CC=C1 NGKSKVYWPINGLI-UHFFFAOYSA-N 0.000 description 2
- UARFKZSJGDQRLF-UHFFFAOYSA-N prop-2-ynylcyclohexane Chemical compound C#CCC1CCCCC1 UARFKZSJGDQRLF-UHFFFAOYSA-N 0.000 description 2
- 229920002554 vinyl polymer Polymers 0.000 description 2
- NDQYHRKAPNXWEY-UHFFFAOYSA-N 1,3,3-triphenylprop-1-en-2-yl dihydrogen phosphate Chemical compound C1=CC=C(C=C1)C=C(C(C2=CC=CC=C2)C3=CC=CC=C3)OP(=O)(O)O NDQYHRKAPNXWEY-UHFFFAOYSA-N 0.000 description 1
- PNXLPYYXCOXPBM-UHFFFAOYSA-N 1,3-diethynylbenzene Chemical compound C#CC1=CC=CC(C#C)=C1 PNXLPYYXCOXPBM-UHFFFAOYSA-N 0.000 description 1
- KBIAVTUACPKPFJ-UHFFFAOYSA-N 1-ethynyl-4-methoxybenzene Chemical compound COC1=CC=C(C#C)C=C1 KBIAVTUACPKPFJ-UHFFFAOYSA-N 0.000 description 1
- APGNXGIUUTWIRE-UHFFFAOYSA-N 4-Pentylphenylacetylene Chemical group CCCCCC1=CC=C(C#C)C=C1 APGNXGIUUTWIRE-UHFFFAOYSA-N 0.000 description 1
- 0 CC(c(cc1)ccc1C(*=O)=C)=C Chemical compound CC(c(cc1)ccc1C(*=O)=C)=C 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- NDQYHRKAPNXWEY-SILNSSARSA-N OP(O)(O/C(\C(C1=CC=CC=C1)C1=CC=CC=C1)=C\C1=CC=CC=C1)=O Chemical compound OP(O)(O/C(\C(C1=CC=CC=C1)C1=CC=CC=C1)=C\C1=CC=CC=C1)=O NDQYHRKAPNXWEY-SILNSSARSA-N 0.000 description 1
- BMDFANPVAUGMGU-UHFFFAOYSA-N P(=O)(OC(=C)CCl)(OC1=CC=CC=C1)OC1=CC=CC=C1 Chemical compound P(=O)(OC(=C)CCl)(OC1=CC=CC=C1)OC1=CC=CC=C1 BMDFANPVAUGMGU-UHFFFAOYSA-N 0.000 description 1
- NKVHTEPISSQIKY-UHFFFAOYSA-N P(=O)(OC(=CC1CCCCC1)C)(OC1=CC=CC=C1)OC1=CC=CC=C1 Chemical compound P(=O)(OC(=CC1CCCCC1)C)(OC1=CC=CC=C1)OC1=CC=CC=C1 NKVHTEPISSQIKY-UHFFFAOYSA-N 0.000 description 1
- TYWBKPQTEMVOGL-UHFFFAOYSA-N P(=O)(OC(C)=CCCCCC)(OC1=CC=CC=C1)OC1=CC=CC=C1 Chemical compound P(=O)(OC(C)=CCCCCC)(OC1=CC=CC=C1)OC1=CC=CC=C1 TYWBKPQTEMVOGL-UHFFFAOYSA-N 0.000 description 1
- NQYUSUGAUNVZRQ-UHFFFAOYSA-N P(=O)(OC(CC)=C/CC)(OC1=CC=CC=C1)OC1=CC=CC=C1 Chemical compound P(=O)(OC(CC)=C/CC)(OC1=CC=CC=C1)OC1=CC=CC=C1 NQYUSUGAUNVZRQ-UHFFFAOYSA-N 0.000 description 1
- LUNHMWWRRYFILU-UHFFFAOYSA-N P(=O)(OC1=CC=CC=C1)(OC1=CC=CC=C1)OC(=C)CCCC1=CC=CC=C1 Chemical compound P(=O)(OC1=CC=CC=C1)(OC1=CC=CC=C1)OC(=C)CCCC1=CC=CC=C1 LUNHMWWRRYFILU-UHFFFAOYSA-N 0.000 description 1
- LPEFFAWUHRBNOW-UHFFFAOYSA-N P(=O)(OC1=CC=CC=C1)(OC1=CC=CC=C1)OC(C)=CCCC1=CC=CC=C1 Chemical compound P(=O)(OC1=CC=CC=C1)(OC1=CC=CC=C1)OC(C)=CCCC1=CC=CC=C1 LPEFFAWUHRBNOW-UHFFFAOYSA-N 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- 239000004305 biphenyl Substances 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- GKIRPKYJQBWNGO-OCEACIFDSA-N clomifene Chemical compound C1=CC(OCCN(CC)CC)=CC=C1C(\C=1C=CC=CC=1)=C(\Cl)C1=CC=CC=C1 GKIRPKYJQBWNGO-OCEACIFDSA-N 0.000 description 1
- ONCCWDRMOZMNSM-FBCQKBJTSA-N compound Z Chemical compound N1=C2C(=O)NC(N)=NC2=NC=C1C(=O)[C@H]1OP(O)(=O)OC[C@H]1O ONCCWDRMOZMNSM-FBCQKBJTSA-N 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- RJYNTEFVOZNXEM-UHFFFAOYSA-N ethenyl diphenyl phosphate Chemical compound C=1C=CC=CC=1OP(=O)(OC=C)OC1=CC=CC=C1 RJYNTEFVOZNXEM-UHFFFAOYSA-N 0.000 description 1
- UTUVIKZNQWNGIM-UHFFFAOYSA-N ethyl 2-phenylpropanoate Chemical compound CCOC(=O)C(C)C1=CC=CC=C1 UTUVIKZNQWNGIM-UHFFFAOYSA-N 0.000 description 1
- FMVJYQGSRWVMQV-UHFFFAOYSA-N ethyl propiolate Chemical compound CCOC(=O)C#C FMVJYQGSRWVMQV-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000012847 fine chemical Substances 0.000 description 1
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 description 1
- 238000006317 isomerization reaction Methods 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- RVRCPTPUOFTXSC-UHFFFAOYSA-N oct-1-en-2-yl diphenyl phosphate Chemical compound C=1C=CC=CC=1OP(=O)(OC(=C)CCCCCC)OC1=CC=CC=C1 RVRCPTPUOFTXSC-UHFFFAOYSA-N 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 238000006053 organic reaction Methods 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- GHUURDQYRGVEHX-UHFFFAOYSA-N prop-1-ynylbenzene Chemical compound CC#CC1=CC=CC=C1 GHUURDQYRGVEHX-UHFFFAOYSA-N 0.000 description 1
- LJZPPWWHKPGCHS-UHFFFAOYSA-N propargyl chloride Chemical compound ClCC#C LJZPPWWHKPGCHS-UHFFFAOYSA-N 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/12—Esters of phosphoric acids with hydroxyaryl compounds
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
- B01J31/24—Phosphines, i.e. phosphorus bonded to only carbon atoms, or to both carbon and hydrogen atoms, including e.g. sp2-hybridised phosphorus compounds such as phosphabenzene, phosphole or anionic phospholide ligands
- B01J31/2404—Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
- B01J2531/10—Complexes comprising metals of Group I (IA or IB) as the central metal
- B01J2531/18—Gold
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
- B01J2531/90—Catalytic systems characterized by the solvent or solvent system used
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
Abstract
Description
본 발명은 신규한 엔올 포스페이트 유도체 및 이의 제조방법에 관한 것이다. 보다 상세하게는, 서로 다른 금 촉매계를 이용하여 알카인 유도체를 포스페이트 유도체와의 첨가반응을 통하여 카이네틱(kinetic) 엔올 포스페이트 유도체와 써모다이나믹(thermodynamic) 엔올 포스페이트 유도체를 각각 선택적으로 제조하는 방법에 관한 것이다.The present invention relates to novel enol phosphate derivatives and methods for their preparation. More specifically, a method of selectively preparing a kinetic enol phosphate derivative and a thermodynamic enol phosphate derivative by respectively adding an alkane derivative to a phosphate derivative using a different gold catalyst system It is about.
엔올 포스페이트 유도체들은 유기화학에서 매우 유용한 중간체로 작용한다. 그 이유로 엔올 포스페이트를 이용하여 다양한 유기화합물의 합성 및 나아가 천연물의 합성에도 이용할 수 있기 때문이다. 일반적인 엔올 포스페이트 합성법은 리튬 엔올레이트와 다이알킬포스포로클로리데이트의 반응을 통해 합성할 수 있다. 특히 써모다이나믹 엔올 유도체의 경우 이들은 비대칭 케톤으로 부터 만들 수 있긴 하지만 높은 선택성을 가지는 써모다이나믹 엔올 유도체를 만들기는 쉽지가 않다. 따라서, 높은 선택성을 가지는 카이네틱 엔올 포스페이트 또는 써모다이나믹 엔올 포스페이트를 합성하는 방법은 매우 중요하다. 특히 기존 방법은 카보닐기 즉, 알데히나 케톤으로부터 엔올 포스페이트를 만들며 따라서 알카인으로부터 포스페이트의 첨가반응을 통해 엔올포스페이트를 만드는 합성방법의 개발은 매우 중요하다.Enol phosphate derivatives serve as very useful intermediates in organic chemistry. This is because the enol phosphate can be used to synthesize various organic compounds and further to synthesize natural products. The general enol phosphate synthesis method can be synthesized through the reaction of lithium enolate and dialkylphosphorochlorate. Especially for thermodynamic enol derivatives, they can be made from asymmetric ketones, but it is not easy to produce thermodynamic enol derivatives with high selectivity. Therefore, the method of synthesizing kinetic enol phosphate or thermodynamic enol phosphate with high selectivity is very important. In particular, the existing methods make enol phosphate from carbonyl groups, that is, aldehyde or ketone, and therefore, the development of a synthetic method of making enol phosphate through the addition reaction of phosphate from alkane is very important.
또한 현재까지 서로 다른 금 촉매계를 이용하여 카이네틱 엔올 포스페이트 유도체 또는 써모다이나믹 엔올 포스페이트 유도체를 선택적으로 합성한 예는 어느 문헌에도 보고되지 않았다.In addition, there have been no reports on the selective synthesis of kinetic enol phosphate derivatives or thermodynamic enol phosphate derivatives using different gold catalyst systems.
본 발명의 목적은 신규한 엔올 포스페이트 유도체를 제공하는데 있다.It is an object of the present invention to provide novel enol phosphate derivatives.
또한, 본 발명의 목적은 다양한 유기반응의 유용한 중간체로 작용하는 엔올 포스페이트 유도체를 알카인으로부터 선택적으로 제조하는 방법을 제공하는 데 있다.It is also an object of the present invention to provide a process for the selective preparation of enol phosphate derivatives from alkane which serve as useful intermediates of various organic reactions.
또한, 본 발명은 서로 다른 금 촉매계를 이용한 알카인 유도체와 포스페이트의 첨가반응을 통해 카이네틱 엔올 포스페이트 유도체와 써모다이나믹 엔올 포스페이트 유도체를 선택적으로 제조하는 방법을 제공하는 데 또 다른 목적이 있다.Another object of the present invention is to provide a method for selectively preparing a kinetic enol phosphate derivative and a thermodynamic enol phosphate derivative by addition of an alkane derivative and a phosphate using different gold catalyst systems.
본 발명은 하기 화학식 1로 표시되는 신규한 엔올 포스페이트 유도체 및 이의 제조방법을 제공한다.The present invention provides a novel enol phosphate derivative represented by the following formula (1) and a preparation method thereof.
[화학식 1][Formula 1]
또한, 본 발명은 하기 화학식 A로 표시되는 카이네틱(kinetic) 엔올 포스페이트 유도체와 하기 화학식 B로 표시되는 써모다이나믹(thermodynamic) 엔올 포스페이트 유도체의 제조방법으로서, 서로 다른 금 촉매를 이용하여 하기 화학식 2와 하기 화학식 3으로 표시되는 알카인 유도체를 하기 화학식 4로 표시되는 포스페이트와의 첨가반응을 통하여 하기 화학식 A로 표시되는 카이네틱 엔올 포스페이트 유도체와 하기 화학식 B로 표시되는 써모다이나믹 엔올 포스페이트 유도체를 선택적으로 제조하는 것을 특징으로 한다. In addition, the present invention is a method for preparing a kinetic enol phosphate derivative represented by the following formula (A) and a thermodynamic enol phosphate derivative represented by the following formula B, using a different gold catalyst And a kinetic enol phosphate derivative represented by the following formula (A) and a thermodynamic enol phosphate derivative represented by the following formula (B) by adding an alkane derivative represented by the following formula (3) to a phosphate represented by the following formula (4): It is characterized in that the manufacturing.
[화학식 A][Formula A]
[화학식 B][Formula B]
[화학식 2][Formula 2]
[화학식 3](3)
[화학식 4][Formula 4]
이하, 본 발명을 상세히 설명한다. Hereinafter, the present invention will be described in detail.
이때, 사용되는 기술 용어 및 과학 용어에 있어서 다른 정의가 없다면, 이 발명이 속하는 기술 분야에서 통상의 지식을 가진 자가 통상적으로 이해하고 있는 의미를 가진다. 또한, 종래와 동일한 기술적 구성 및 작용에 대한 반복되는 설명은 생략하기로 한다. At this time, if there is no other definition in the technical terms and scientific terms used, it has a meaning commonly understood by those of ordinary skill in the art. Repeated descriptions of the same technical constitution and operation as those of the conventional art will be omitted.
본 발명은 하기 화학식 1로 표시되는 엔올 포스페이트 유도체를 제공한다.The present invention provides an enol phosphate derivative represented by the following formula (1).
[화학식 1][Formula 1]
[R1은 수소, (C1~C7)알킬, 할로(C1-C7)알킬, (C6-C20)아릴(C1-C7)알킬, (C6-C20)아릴티오, (C6-C20)아릴(C1-C7)알킬티오, (C1~C7)알킬옥시카보닐, (C6-C20)아릴, 할로(C6-C20)아릴, 페로세닐 또는 이며;[R 1 is hydrogen, (C1-C7) alkyl, halo (C1-C7) alkyl, (C6-C20) aryl (C1-C7) alkyl, (C6-C20) arylthio, (C6-C20) aryl (C1 -C7) alkylthio, (C1-C7) alkyloxycarbonyl, (C6-C20) aryl, halo (C6-C20) aryl, ferrocenyl or Is;
R2는 (R2 및 R3) 수소, (C1~C8)알킬, 할로(C1-C8)알킬, (C3-C7)사이클로알킬, (C1-C7)알콕시카보닐, (C6-C20)아릴티오, (C6-C20)아릴 또는 (C6-C20)아릴(C1-C8)알킬이고;R 2 is (R 2 And R 3 ) hydrogen, (C1-C8) alkyl, halo (C1-C8) alkyl, (C3-C7) cycloalkyl, (C1-C7) alkoxycarbonyl, (C6-C20) arylthio, (C6-C20 ) Aryl or (C6-C20) aryl (C1-C8) alkyl;
R3는 (C6-C20)아릴, (C1-C7)알킬 또는 (C6-C20)아릴(C1-C7)알킬이고;R 3 is (C6-C20) aryl, (C1-C7) alkyl or (C6-C20) aryl (C1-C7) alkyl;
상기 R1 및 R2의 알킬 및 아릴은 (C1-C7)알킬, 할로(C1-C7)알킬, (C1-C7)알콕시, (C1-C7)알킬카보닐옥시, (C6-C20)아릴(C1-C7)알킬옥시, 시아노, (C1-C7)알킬(C6-C20)아릴옥시 및 (C3-C7)사이클로알킬로 이루어진 군으로부터 선택되는 하나 이상으로 더 치환될 수 있다.]Alkyl and aryl of R 1 and R 2 are (C 1 -C 7) alkyl, halo (C 1 -C 7) alkyl, (C 1 -C 7) alkoxy, (C 1 -C 7) alkylcarbonyloxy, (C 6 -C 20) aryl ( C1-C7) alkyloxy, cyano, (C1-C7) alkyl (C6-C20) aryloxy and (C3-C7) cycloalkyl may be further substituted with one or more selected.]
상기 '알킬'은 직쇄상 또는 분쇄상의 탄소사슬을 모두 포함한다.The 'alkyl' includes both linear or pulverized carbon chains.
구체적으로 상기 화학식 1에서 R1은 수소, 메틸, 에틸, 헥실, 벤질, 페닐프로필, 클로로메틸, 브로모메틸, 클로로에틸, 클로로프로필, 시아노프로필, 메틸카보닐옥시메틸, 벤질옥시프로필, 다이메틸페녹시프로필, 사이클로헥실메틸, 벤질티오, 페닐티오, 에톡시카보닐, 페닐, 펜틸페닐, 트리플루오로메틸페닐, 클로로페닐, 페로세닐, 메톡시페닐 또는 이며; R2는 수소, 에틸, 펜틸, 헥실, 사이클로헥실, 페닐에틸, 클로로에틸, 에톡시카보닐, 페닐, 페닐티오, 메틸카보닐옥시메틸 또는 클로로페닐이고; R3 페닐, 메틸, 에틸, 프로필 또는 벤질이다.Specifically in Formula 1 R 1 is hydrogen, methyl, ethyl, hexyl, benzyl, phenylpropyl, chloromethyl, bromomethyl, chloroethyl, chloropropyl, cyanopropyl, methylcarbonyloxymethyl, benzyloxypropyl, di Methylphenoxypropyl, cyclohexylmethyl, benzylthio, phenylthio, ethoxycarbonyl, phenyl, pentylphenyl, trifluoromethylphenyl, chlorophenyl, ferrocenyl, methoxyphenyl or Is; R 2 is hydrogen, ethyl, pentyl, hexyl, cyclohexyl, phenylethyl, chloroethyl, ethoxycarbonyl, phenyl, phenylthio, methylcarbonyloxymethyl or chlorophenyl; R 3 is phenyl, methyl, ethyl, propyl or benzyl.
본 발명의 엔올 포스페이트 유도체는 하기 구조의 화합물로부터 선택되나, 이에 한정되는 것은 아니다.Enol phosphate derivatives of the present invention are selected from, but not limited to, compounds of the structure:
또한, 본 발명은 하기 화학식 A로 표시되는 카이네틱 엔올 포스페이트 유도체와 하기 화학식 B로 표시되는 써모다이나믹 엔올 포스페이트 유도체의 제조방법을 권리범위로 포함한 바, 본 발명에 따른 제조방법을 이하 상세히 설명한다. 하기 화학식 2로 표시되는 알카인 유도체를 하기 화학식 4로 표시되는 포스페이트와 금 촉매를 이용한 첨가반응을 통해 하기 화학식 A로 표시되는 카이네틱 엔올 포스페이트를 제조하는 과정(반응식 1)과 하기 화학식 3으로 표시되는 알카인 유도체를 다른 금 촉매를 이용하여 하기 화학식 4로 표시되는 포스페이트와의 첨가반응 및 이성질화 반응을 통해 하기 화학식 B로 표시되는 써모다이나믹 엔올 포스페이트 유도체를 알카인 유도체로부터 선택적으로 제조하는 과정(반응식 2)을 포함하는 제조방법을 포함한다. In addition, the present invention includes the preparation method of the kinetic enol phosphate derivative represented by the following general formula (A) and the thermodynamic enol phosphate derivative represented by the following general formula (B) as a scope, and the preparation method according to the present invention will be described in detail below. . To prepare a kinetic enol phosphate represented by the following formula (A) through the addition of the alkane derivative represented by the formula (2) using a phosphate and a gold catalyst represented by the following formula (4) (Scheme 1) and A process of selectively preparing a thermodynamic enol phosphate derivative represented by the following formula (B) from an alkane derivative through addition and isomerization with an phosphate represented by the following formula (4) using another gold catalyst It includes the manufacturing method containing (Scheme 2).
[반응식 1]Scheme 1
[상기 반응식 1에서, R1은 수소, (C1~C7)알킬, 할로(C1-C7)알킬, (C6-C20)아릴(C1-C7)알킬, (C6-C20)아릴티오, (C6-C20)아릴(C1-C7)알킬티오, (C1~C7)알킬옥시카보닐, (C6-C20)아릴, 할로(C6-C20)아릴, 페로세닐 또는 이며; R2는 수소, (C1~C7)알킬, (C1-C7)알콕시카보닐, (C6-C20)아릴티오 또는 (C6-C20)아릴이고; R3는 (C6-C20)아릴, (C1-C7)알킬 또는 (C6-C20)아릴(C1-C7)알킬이고; 상기 R1 및 R2의 알킬 및 아릴은 (C1-C7)알킬, 할로(C1-C7)알킬, (C1-C7)알콕시, (C1-C7)알킬카보닐옥시, (C6-C20)아릴(C1-C7)알킬옥시, 시아노, (C1-C7)알킬(C6-C20)아릴옥시 및 (C3-C7)사이클로알킬로 이루어진 군으로부터 선택되는 하나 이상으로 더 치환될 수 있다.]
[In Scheme 1, R 1 is hydrogen, (C1-C7) alkyl, halo (C1-C7) alkyl, (C6-C20) aryl (C1-C7) alkyl, (C6-C20) arylthio, (C6- C20) aryl (C1-C7) alkylthio, (C1-C7) alkyloxycarbonyl, (C6-C20) aryl, halo (C6-C20) aryl, ferrocenyl or Is; R 2 is hydrogen, (C1-C7) alkyl, (C1-C7) alkoxycarbonyl, (C6-C20) arylthio or (C6-C20) aryl; R 3 is (C6-C20) aryl, (C1-C7) alkyl or (C6-C20) aryl (C1-C7) alkyl; Alkyl and aryl of R 1 and R 2 are (C 1 -C 7) alkyl, halo (C 1 -C 7) alkyl, (C 1 -C 7) alkoxy, (C 1 -C 7) alkylcarbonyloxy, (C 6 -C 20) aryl ( C1-C7) alkyloxy, cyano, (C1-C7) alkyl (C6-C20) aryloxy and (C3-C7) cycloalkyl may be further substituted with one or more selected.]
[반응식 2]Scheme 2
[상기 반응식 2에서, R2는 (C1~C7)알킬, 할로(C1-C7)알킬, (C3-C7)사이클로알킬, (C6-C20)아릴 또는 (C6-C20)아릴(C1-C7)알킬이고; R3는 (C6-C20)아릴, (C1-C7)알킬 또는 (C6-C20)아릴(C1-C7)알킬이다.] [In Scheme 2, R 2 is (C1-C7) alkyl, halo (C1-C7) alkyl, (C3-C7) cycloalkyl, (C6-C20) aryl or (C6-C20) aryl (C1-C7) Alkyl; R 3 is (C6-C20) aryl, (C1-C7) alkyl or (C6-C20) aryl (C1-C7) alkyl]
본 발명의 제조방법에서 사용되는 반응용기는 둥근바닥 플라스크, 테스트 튜브 및 V-바이알로 이루어진 군에서 선택되는 것이 바람직하며, V-바이알을 사용하는 것이 더욱 바람직하다. The reaction vessel used in the production method of the present invention is preferably selected from the group consisting of a round bottom flask, a test tube and a V-vial, more preferably using a V-vial.
본 발명의 제조방법에서 사용되는 금 촉매는 AuCl, AuCl3, AuBr3, PPh3AuCl, (C6F5)3PAuCl, (IPr)AuCl, (IMes)AuCl로 이루어지는 군으로부터 1종 이상 선택되는 것이 바람직하며 카이네틱 엔올 포스페이트 유도체 (화학식 A)를 제조시 PPh3AuCl를 촉매로 사용하는 것이 더욱 바람직하며, 써모다이나믹 엔올 포스페이트 유도체 (화학식 B)를 제조시 (C6F5)3PAuCl를 촉매로 사용하는 것이 더욱 바람직하다.The gold catalyst used in the preparation method of the present invention is at least one selected from the group consisting of AuCl, AuCl 3 , AuBr 3 , PPh 3 AuCl, (C 6 F 5 ) 3 PAuCl, (IPr) AuCl, (IMes) AuCl Preference is given to the use of PPh 3 AuCl as catalyst in the preparation of the kinetic enol phosphate derivative (Formula A), and to the preparation of the thermodynamic enol phosphate derivative (Formula B) (C 6 F 5 ) 3 PAuCl. More preferably used as a catalyst.
본 발명의 제조방법에서는 상기 금 촉매 외에 은 촉매를 병용하여 금 촉매의 루이스 산도를 높임으로써 반응의 선택성 및 수율 측면에서 더욱 바람직하다. 본 발명의 제조방법에서 사용되는 은 촉매는 AgOTf, AgBF4, AgAsF6, AgNTf2, AgSbF6, AgPF6 , AgNO3로 이루어진 군으로부터 1종 이상 선택되는 것이 바람직하며 카이네틱 엔올 포스페이트 유도체 (화학식 A)를 제조시 AgPF6를 금 촉매와 더불어 사용하는 것이 더욱 바람직하며, 써모다이나믹 엔올 포스페이트 유도체 (화학식 B)를 제조시 AgOTf 를 금 촉매와 더불어 사용하는 것이 더욱 바람직하다.In the production method of the present invention, the silver catalyst is used in addition to the gold catalyst to increase the Lewis acidity of the gold catalyst, which is more preferable in view of selectivity and yield of the reaction. The silver catalyst used in the preparation method of the present invention is preferably selected from the group consisting of AgOTf, AgBF 4 , AgAsF 6 , AgNTf 2 , AgSbF 6 , AgPF 6 , AgNO 3 , a kinetic enol phosphate derivative It is more preferable to use AgPF 6 together with the gold catalyst in the preparation of A), and more preferably to use AgOTf together with the gold catalyst in the preparation of the thermodynamic enol phosphate derivative (Formula B).
본 발명의 제조방법에서 사용되는 금 촉매의 양은 상기 화학식 4로 표시되는 포스페이트 유도체에 대하여 1 내지 10 mol%를 사용하는 것이 바람직하며 5 mol%를 사용하는 것이 더욱 바람직하다.The amount of the gold catalyst used in the production method of the present invention is preferably used 1 to 10 mol%, more preferably 5 mol% based on the phosphate derivative represented by the formula (4).
본 발명의 제조방법에서 사용되는 은 촉매의 양은 사용되는 금 촉매에 따라 다르며, 1가의 금 촉매를 사용시 상기 은 촉매는 금 촉매와 같은 당량을 사용하는 것이 바람직하고, 1 당량을 사용하는 것이 더욱 바람직하며, 3가의 금 촉매를 사용시 상기 은 촉매는 금 촉매에 대해 2 내지 5 당량을 사용하는 것이 바람직하고, 3 당량을 사용하는 것이 더욱 바람직하다.The amount of the silver catalyst used in the production method of the present invention depends on the gold catalyst used, and when using a monovalent gold catalyst, the silver catalyst preferably uses the same equivalents as the gold catalyst, and more preferably 1 equivalent. In addition, when using a trivalent gold catalyst, it is preferable to use 2-5 equivalents with respect to a gold catalyst, and, as for the said silver catalyst, it is more preferable to use 3 equivalents.
본 발명의 제조방법에서 사용되는 알카인 유도체(2, 3)는 포스페이트 유도체(4)에 대해 1 내지 2 당량을 사용하는 것이 바람직하며 1.2 당량을 사용하는 것이 더욱 바람직하다.The alkane derivatives (2, 3) used in the preparation method of the present invention preferably use 1 to 2 equivalents, more preferably 1.2 equivalents, relative to the phosphate derivative (4).
본 발명의 제조방법에서 사용되는 용매는 통상의 유기용매이며 다이클로로메탄(DCM), 다이클로로에탄(DCE), 톨루엔(Toluene), 아세토나이트릴(MeCN), 나이트로메탄(Nitromethan), 테트라하이드로퓨란(THF), N,N-다이메틸포름아마이드(DMF), N,N-다이메틸아세트아마이드(DMA)로 이루어진 군으로부터 1종 이상 선택되는 것이 바람직하며 톨루엔(Toluene)을 용매로 사용하는 것이 더욱 바람직하다. The solvent used in the preparation method of the present invention is a conventional organic solvent, dichloromethane (DCM), dichloroethane (DCE), toluene (Toluene), acetonitrile (MeCN), nitromethan (tetraethan), tetrahydro It is preferable that at least one selected from the group consisting of furan (THF), N, N -dimethylformamide (DMF) and N, N -dimethylacetamide (DMA) is used, and toluene is used as a solvent. More preferred.
반응온도는 20 내지 140 ℃에서 상기 반응을 수행하며, 사용되는 알카인 유도체에 따라 다를 수 있다. The reaction temperature is carried out at 20 to 140 ° C and may vary depending on the alkane derivative used.
반응시간은 반응물질, 용매의 종류 및 용매의 양에 따라 달라질 수 있으며, TLC 등을 통하여 출발물질인 알카인 유도체가 소모됨을 확인 후 반응을 완결시키도록 한다. 반응이 완결되면 추출과정 후 감압 하에서 용매를 증류시킨 후 관 크로마토그래피 등의 통상의 방법을 통하여 목적물을 분리 정제할 수도 있다.The reaction time may vary depending on the reactants, the type of solvent, and the amount of the solvent. After confirming that the starting material alkane derivative is consumed through TLC, the reaction is completed. After the reaction is completed, the solvent may be distilled off under reduced pressure after the extraction process, and the desired product may be separated and purified through a conventional method such as column chromatography.
본 발명에 따른 신규한 엔올 포스페이트 유도체는 유기 합성에서 매우 중요한 중간체로, 의약 및 신규 물질 합성에 이용가능하거나, 농약을 포함한 정밀 화학 중간체 등의 합성에 이용가능하고, 또한 천연물 및 생리활성 물질의 합성시에도 이용가능하다. 본 발명에 따른 카이네틱 엔올 포스페이트 및 써모다이나믹 엔올 포스페이트의 선택적인 제조방법을 통해 다양한 유기물질을 합성할 수 있으며 나아가 천연물이나 의약품의 개발이 가능하다. 또한 본 발명에 따른 카이네틱 엔올 포스페이트 및 써모다이나믹 엔올 포스페이트 유도체를 서로 다른 금 촉매 존재하에서 다양한 알카인 유도체와 포스페이트 유도체와의 첨가반응으로 높은 수율과 간단한 실험과정을 통해 선택적으로 제조할 수 있는 장점을 가진다.The novel enol phosphate derivatives according to the present invention are very important intermediates in organic synthesis and can be used for the synthesis of medicinal and novel substances, or for the synthesis of fine chemical intermediates including pesticides, and also for the synthesis of natural and bioactive substances. It is also available in the city. Through the selective manufacturing method of the kinetic enol phosphate and thermodynamic enol phosphate according to the invention it is possible to synthesize a variety of organic materials and further development of natural products or pharmaceuticals. In addition, the kinetic enol phosphate and thermodynamic enol phosphate derivatives according to the present invention can be selectively prepared through high yields and simple experiments by addition reaction between various alkane derivatives and phosphate derivatives in the presence of different gold catalysts. Has
이하, 실시예를 통하여 본 발명의 구성을 보다 구체적으로 설명하지만, 하기의 실시예 들은 본 발명에 대한 이해를 돕기 위한 것으로서, 본 발명의 범위가 여기에 국한된 것은 아니다.
Hereinafter, the configuration of the present invention in more detail through examples, the following examples are provided to help the understanding of the present invention, the scope of the present invention is not limited thereto.
[실시예 1] 옥트-1-엔-2-일 다이페닐 포스페이트 (Oct-1-en-2-yl diphenyl phosphate)의 제조Example 1 Preparation of Oct-1-en-2-yl diphenyl phosphate
V-바이알에 PPh3AuCl (12.4 mg, 0.025 mmol)과 AgPF6 (6.3 mg, 0.025 mmol)를 넣고 톨루엔 (2 mL)를 넣어 실온에서 교반시키고 여기에 다이페닐 포스페이트 (125 mg, 0.5 mmol)와 1-옥틴 (66 mg, 0.6 mmol)을 차례로 첨가하여 실온에서 9 시간 교반시킨 후 반응을 종결시켰다. 용매를 제거한 후 관 크로마토그래피로 분리하여, 표제화합물인 옥트-1-엔-2-일 다이페닐 포스페이트 (159 mg, 88 %) 를 얻었다.To a V-vial, add PPh 3 AuCl (12.4 mg, 0.025 mmol) and AgPF 6 (6.3 mg, 0.025 mmol), add toluene (2 mL) and stir at room temperature, add diphenyl phosphate (125 mg, 0.5 mmol) and 1-octin (66 mg, 0.6 mmol) was added sequentially and stirred at room temperature for 9 hours before terminating the reaction. The solvent was removed and the residue was separated by column chromatography to obtain the title compound oct-1-en-2-yl diphenyl phosphate (159 mg, 88%).
1H NMR (400 MHz, CDCl3) δ 7.37-7.33 (m, 4H), 7.25-7.19 (m, 6H), 4.93 (t, J = 2.2 Hz, 1H), 4.59 (t, J = 2.0 Hz, 1H), 2.19 (t, J = 7.6 Hz, 2H), 1.44 (quint, J = 7.4 Hz, 2H), 1.31-1.19 (m, 6H), 0.87 (t, J = 6.9 Hz, 3H)
1 H NMR (400 MHz, CDCl 3 ) δ 7.37-7.33 (m, 4H), 7.25-7.19 (m, 6H), 4.93 (t, J = 2.2 Hz, 1H), 4.59 (t, J = 2.0 Hz, 1H), 2.19 (t, J = 7.6 Hz , 2H), 1.44 (quint , J = 7.4 Hz, 2H), 1.31-1.19 (m, 6H), 0.87 (t, J = 6.9 Hz, 3H)
[실시예 2] 3-페닐-1-프로펜-2-일 다이페닐 포스페이트 (3-Phenyl-1-propen-2-yl diphenyl phosphate)의 제조Example 2 Preparation of 3-Phenyl-1-propen-2-yl diphenyl phosphate
V-바이알에 PPh3AuCl (12.4 mg, 0.025 mmol)과 AgPF6 (6.3 mg, 0.025 mmol)를 넣고 톨루엔 (2 mL)를 넣어 실온에서 교반시키고 여기에 다이페닐 포스페이트 (125 mg, 0.5 mmol)와 3-페닐-1-프로핀 (78 mg, 0.6 mmol)을 차례로 첨가하여 실온에서 9 시간 교반시킨 후 반응을 종결시켰다. 용매를 제거한 후 관 크로마토그래피로 분리하여, 표제화합물인 3-페닐-1-프로펜-2-일 다이페닐 포스페이트 (146 mg, 88 %) 를 얻었다.To a V-vial, add PPh 3 AuCl (12.4 mg, 0.025 mmol) and AgPF 6 (6.3 mg, 0.025 mmol), add toluene (2 mL) and stir at room temperature, add diphenyl phosphate (125 mg, 0.5 mmol) and 3-phenyl-1-propyne (78 mg, 0.6 mmol) was added sequentially and stirred at room temperature for 9 hours before terminating the reaction. After the solvent was removed, the residue was separated by column chromatography to obtain 3-phenyl-1-propen-2-yl diphenyl phosphate (146 mg, 88%) as a title compound.
1H NMR (400 MHz, CDCl3 , 25℃, TMS): δ 7.34-7.24 (m, 8H), 7.22-7.13 (m, 7H) 5.05 (t, J = 2.2 Hz, 2H), 4.59 (t, J = 1.8 Hz, 1H), 3.51 (s, 1H)
1 H NMR (400 MHz, CDCl 3 , 25 ° C., TMS): δ 7.34-7.24 (m, 8H), 7.22-7.13 (m, 7H) 5.05 (t, J = 2.2 Hz, 2H), 4.59 (t, J = 1.8 Hz, 1H), 3.51 (s, 1H)
[실시예 3] 다이페닐 5-페닐펜트-1-엔-2일 포스페이트(diphenyl 5-phenylpent-1-en-2-yl phosphate)의 제조Example 3 Preparation of Diphenyl 5-phenylpent-1-en-2-yl phosphate
V-바이알에 PPh3AuCl (12.4 mg, 0.025 mmol)과 AgPF6 (6.3 mg, 0.025 mmol)를 넣고 톨루엔 (2 mL)를 넣어 실온에서 교반시키고 여기에 다이페닐 포스페이트 (125 mg, 0.5 mmol)와 5-페닐-1-펜틴 (87 mg, 0.6 mmol)을 차례로 첨가하여 실온에서 9 시간 교반시킨 후 반응을 종결시켰다. 용매를 제거한 후 관 크로마토그래피로 분리하여, 표제화합물인 다이페닐 5-페닐펜트-1-엔-2일 포스페이트 (160 mg, 81 %) 를 얻었다.To a V-vial, add PPh 3 AuCl (12.4 mg, 0.025 mmol) and AgPF 6 (6.3 mg, 0.025 mmol), add toluene (2 mL) and stir at room temperature, add diphenyl phosphate (125 mg, 0.5 mmol) and 5-phenyl-1-pentin (87 mg, 0.6 mmol) was added sequentially and stirred at room temperature for 9 hours before terminating the reaction. The solvent was removed and the residue was separated by column chromatography to obtain the title compound diphenyl 5-phenylpent-1-en-2yl phosphate (160 mg, 81%).
1H NMR (400 MHz, CDCl3): δ 7.3-7.4 (m, 4H), 7.2-7.3 (m, 9H), 7.11-7.13 (m, 2H), 4.97 (t, J = 2.2 Hz, 1H), 4.62 (s, 1H), 2.60 (t, J = 7.7 Hz, 2H), 2.24 (t, J = 7.5 Hz, 2H), 1.78 (q, J =7.6 Hz, 2H)
1 H NMR (400 MHz, CDCl 3 ): δ 7.3-7.4 (m, 4H), 7.2-7.3 (m, 9H), 7.11-7.13 (m, 2H), 4.97 (t, J = 2.2 Hz, 1H) , 4.62 (s, 1H), 2.60 (t, J = 7.7 Hz, 2H), 2.24 (t, J = 7.5 Hz, 2H), 1.78 (q, J = 7.6 Hz, 2H)
[실시예 4] 1-(1-사이클로헥실메틸)바이닐 다이페닐 포스페이트 (1-(1-Cyclohexylmethyl)vinyl diphenyl phosphate)의 제조Example 4 Preparation of 1- (1-cyclohexylmethyl) vinyl diphenyl phosphate (1- (1-Cyclohexylmethyl) vinyl diphenyl phosphate)
V-바이알에 PPh3AuCl (12.4 mg, 0.025 mmol)과 AgPF6 (6.3 mg, 0.025 mmol)를 넣고 톨루엔 (2 mL)를 넣어 실온에서 교반시키고 여기에 다이페닐 포스페이트 (125 mg, 0.5 mmol)와 3-사이클로헥실-1-프로핀 (73 mg, 0.6 mmol)을 차례로 첨가하여 실온에서 17 시간 교반시킨 후 반응을 종결시켰다. 용매를 제거한 후 관 크로마토그래피로 분리하여, 표제화합물인 1-(1-사이클로헥실메틸)바이닐 다이페닐 포스페이트 (177 mg, 95 %) 를 얻었다.To a V-vial, add PPh 3 AuCl (12.4 mg, 0.025 mmol) and AgPF 6 (6.3 mg, 0.025 mmol), add toluene (2 mL) and stir at room temperature, add diphenyl phosphate (125 mg, 0.5 mmol) and 3-cyclohexyl-1-propyne (73 mg, 0.6 mmol) was added sequentially and stirred at room temperature for 17 hours before terminating the reaction. The solvent was removed and the residue was separated by column chromatography to obtain 1- (1-cyclohexylmethyl) vinyl diphenyl phosphate (177 mg, 95%) as a title compound.
1H NMR (400 MHz, CDCl3): δ 7.37-7.34 (m, 4H), 7.26-7.24 (m, 4H), 7.22-7.19 (m, 2H), 4.93 (t, J = 2.1 Hz, 1H), 4.56 (t, J = 2.1 Hz, 1H), 2.06 (d, J = 7.1 Hz, 2H), 1.69-1.60 (m, 5H), 1.46-1.40 (m, 1H), 1.19-1.08 (m, 3H), 0.88-0.79 (m, 2H)
1 H NMR (400 MHz, CDCl 3 ): δ 7.37-7.34 (m, 4H), 7.26-7.24 (m, 4H), 7.22-7.19 (m, 2H), 4.93 (t, J = 2.1 Hz, 1H) , 4.56 (t, J = 2.1 Hz, 1H), 2.06 (d, J = 7.1 Hz, 2H), 1.69-1.60 (m, 5H), 1.46-1.40 (m, 1H), 1.19-1.08 (m, 3H ), 0.88-0.79 (m, 2H)
[실시예 5] 3-클로로프로프-1-엔-2-일 다이페닐 포스페이스 (3-chloroprop-1-en-2-yl diphenyl phosphate)의 제조Example 5 Preparation of 3-chloroprop-1-en-2-yl diphenyl phosphate
V-바이알에 PPh3AuCl (12.4 mg, 0.025 mmol)과 AgPF6 (6.3 mg, 0.025 mmol)를 넣고 톨루엔 (2 mL)를 넣어 실온에서 교반시키고 여기에 다이페닐 포스페이트 (125 mg, 0.5 mmol)와 프로파질클로라이드 (45 mg, 0.6 mmol)을 차례로 첨가하여 실온에서 15 시간 교반시킨 후 반응을 종결시켰다. 용매를 제거한 후 관 크로마토그래피로 분리하여, 표제화합물인 3-클로로프로프-1-엔-2-일 다이페닐 포스페이스 (122 mg, 70 %) 를 얻었다.To a V-vial, add PPh 3 AuCl (12.4 mg, 0.025 mmol) and AgPF 6 (6.3 mg, 0.025 mmol), add toluene (2 mL) and stir at room temperature, add diphenyl phosphate (125 mg, 0.5 mmol) and Propargylchloride (45 mg, 0.6 mmol) was added sequentially and stirred at room temperature for 15 hours before terminating the reaction. After the solvent was removed, the residue was separated by column chromatography to obtain 3-chloroprop-1-en-2-yl diphenyl space (122 mg, 70%) as a title compound.
1H NMR (400 MHz, CDCl3): δ 7.25-7.29 (m, 4H), 7.10-7.17 (m, 6H), 5.09 (t, J = 2.5 Hz, 1H), 4.93 ( t, J = 2.4 Hz, 1H), 3.96 (s, 2H)
1 H NMR (400 MHz, CDCl 3 ): δ 7.25-7.29 (m, 4H), 7.10-7.17 (m, 6H), 5.09 (t, J = 2.5 Hz, 1H), 4.93 (t, J = 2.4 Hz , 1H), 3.96 (s, 2H)
[실시예 6] 3-브로모-1-프로펜-2-일 다이페닐 포스페이트 (3-Bromo-1-propen-2-yl diphenyl phosphate)의 제조Example 6 Preparation of 3-Bromo-1-propen-2-yl diphenyl phosphate
V-바이알에 PPh3AuCl (12.4 mg, 0.025 mmol)과 AgPF6 (6.3 mg, 0.025 mmol)를 넣고 톨루엔 (2 mL)를 넣어 실온에서 교반시키고 여기에 다이페닐 포스페이트 (125 mg, 0.5 mmol)와 프로파질브로마이드 (71 mg, 0.6 mmol)을 차례로 첨가하여 실온에서 16 시간 교반시킨 후 반응을 종결시켰다. 용매를 제거한 후 관 크로마토그래피로 분리하여, 표제화합물인 3-브로모-1-프로펜-2-일 다이페닐 포스페이트 (170 mg, 92 %) 를 얻었다.To a V-vial, add PPh 3 AuCl (12.4 mg, 0.025 mmol) and AgPF 6 (6.3 mg, 0.025 mmol), add toluene (2 mL) and stir at room temperature, add diphenyl phosphate (125 mg, 0.5 mmol) and Propazilbromide (71 mg, 0.6 mmol) was added in sequence and stirred at room temperature for 16 hours before terminating the reaction. After the solvent was removed, the residue was separated by column chromatography to obtain 3-bromo-1-propen-2-yl diphenyl phosphate (170 mg, 92%) as a title compound.
1H NMR (400 MHz, CDCl3) δ 7.26-7.36 (m, 10H), 5.17 (s, 1H), 5.03 (s, 1H), 3.95 (s, 2H)
1 H NMR (400 MHz, CDCl 3 ) δ 7.26-7.36 (m, 10H), 5.17 (s, 1H), 5.03 (s, 1H), 3.95 (s, 2H)
[실시예 7] 1-(3-클로로프로필)바이닐 다이페닐 포스페이트 (1-(3-Chloropropyl)vinyl diphenyl phosphate)의 제조Example 7 Preparation of 1- (3-Chloropropyl) vinyl diphenyl phosphate (1- (3-Chloropropyl) vinyl diphenyl phosphate)
V-바이알에 PPh3AuCl (12.4 mg, 0.025 mmol)과 AgPF6 (6.3 mg, 0.025 mmol)를 넣고 톨루엔 (2 mL)를 넣어 실온에서 교반시키고 여기에 다이페닐 포스페이트 (125 mg, 0.5 mmol)와 5-클로로-1-펜틴 (62 mg, 0.6 mmol)을 차례로 첨가하여 실온에서 7 시간 교반시킨 후 반응을 종결시켰다. 용매를 제거한 후 관 크로마토그래피로 분리하여, 표제화합물인 1-(3-클로로프로필)바이닐 다이페닐 포스페이트 (138 mg, 78 %) 를 얻었다.To a V-vial, add PPh 3 AuCl (12.4 mg, 0.025 mmol) and AgPF 6 (6.3 mg, 0.025 mmol), add toluene (2 mL) and stir at room temperature, add diphenyl phosphate (125 mg, 0.5 mmol) and 5-chloro-1-pentin (62 mg, 0.6 mmol) was added sequentially and stirred at room temperature for 7 hours before terminating the reaction. After the solvent was removed, the residue was separated by column chromatography to obtain 1- (3-chloropropyl) vinyl diphenyl phosphate (138 mg, 78%) as a title compound.
1H NMR (400 MHz, CDCl3): δ 7.34-7.38 (m, 4H), 7.20-7.26 (m, 6H), 5.02 (s, 1H), 4.68 (s, 1H), 2.39 (t, J = 7.3 Hz, 2H), 1.91 (q, J = 6.8 Hz, 2H)
1 H NMR (400 MHz, CDCl 3 ): δ 7.34-7.38 (m, 4H), 7.20-7.26 (m, 6H), 5.02 (s, 1H), 4.68 (s, 1H), 2.39 (t, J = 7.3 Hz, 2H), 1.91 (q, J = 6.8 Hz, 2H)
[실시예 8] 5-(벤질로시)펜트-1-엔-2-일 다이페닐 포스페이트 (5-(Benzyloxy)pent-1-en-2-yl diphenyl phosphate)의 제조Example 8 Preparation of 5- (benzyloxy) pent-1-en-2-yl diphenyl phosphate (5- (Benzyloxy) pent-1-en-2-yl diphenyl phosphate)
V-바이알에 PPh3AuCl (12.4 mg, 0.025 mmol)과 AgPF6 (6.3 mg, 0.025 mmol)를 넣고 톨루엔 (2 mL)를 넣어 실온에서 교반시키고 여기에 다이페닐 포스페이트 (125 mg, 0.5 mmol)와 ((펜트-4-이닐로시)메틸)벤젠 (104.5 mg, 0.6 mmol)을 차례로 첨가하여 80 ℃에서 4 시간 교반시킨 후 반응을 종결시켰다. 용매를 제거한 후 관 크로마토그래피로 분리하여, 표제화합물인 5-(벤질로시)펜트-1-엔-2-일 다이페닐 포스페이트 (169.8 mg, 80 %) 를 얻었다.To a V-vial, add PPh 3 AuCl (12.4 mg, 0.025 mmol) and AgPF 6 (6.3 mg, 0.025 mmol), add toluene (2 mL) and stir at room temperature, add diphenyl phosphate (125 mg, 0.5 mmol) and ((Pent-4-ynilocy) methyl) benzene (104.5 mg, 0.6 mmol) was added sequentially and stirred at 80 ° C. for 4 hours before terminating the reaction. The solvent was removed and the residue was separated by column chromatography to obtain 5- (benzyloxy) pent-1-en-2-yl diphenyl phosphate (169.8 mg, 80%) as a title compound.
1H NMR (300 MHz, CDCl3): δ 7.35-7.32 (m, 10H), 7.25-6.91 (m, 5H), 4.96 (t, J = 2.2 Hz, 1H), 4.61 (t, J = 2.2 Hz, 1H), 4.47 (s, 2H), 3.46 (t, J = 15.2 Hz, 2H), 2.33 (t, J = 7.5 Hz, 2H), 1.75 (qunt, J = 6.2 Hz, 2H)
1 H NMR (300 MHz, CDCl 3 ): δ 7.35-7.32 (m, 10H), 7.25-6.91 (m, 5H), 4.96 (t, J = 2.2 Hz, 1H), 4.61 (t, J = 2.2 Hz, 1H), 4.47 (s, 2H), 3.46 (t, J = 15.2 Hz, 2H), 2.33 (t, J = 7.5 Hz, 2H), 1.75 (qunt, J = 6.2 Hz, 2H)
[실시예 9] 5-싸이아노펜트-1-엔-2-일 다이페닐 포스페이트 (5-Cyanopent-1-en-2-yl diphenyl phosphate)의 제조Example 9 Preparation of 5-Cyanopent-1-en-2-yl diphenyl phosphate (5-Cyanopent-1-en-2-yl diphenyl phosphate)
V-바이알에 PPh3AuCl (12.4 mg, 0.025 mmol)과 AgPF6 (6.3 mg, 0.025 mmol)를 넣고 톨루엔 (2 mL)를 넣어 실온에서 교반시키고 여기에 다이페닐 포스페이트 (125 mg, 0.5 mmol)와 5-헥사인나이트릴(55.9 mg, 0.6 mmol)을 차례로 첨가하여 실온에서 8 시간 교반시킨 후 반응을 종결시켰다. 용매를 제거한 후 관 크로마토그래피로 분리하여, 표제화합물인 5-싸이아노펜트-1-엔-2-일 다이페닐 포스페이트 (137 mg, 80 %) 를 얻었다.To a V-vial, add PPh 3 AuCl (12.4 mg, 0.025 mmol) and AgPF 6 (6.3 mg, 0.025 mmol), add toluene (2 mL) and stir at room temperature, add diphenyl phosphate (125 mg, 0.5 mmol) and 5-hexaninnitrile (55.9 mg, 0.6 mmol) was added sequentially and stirred at room temperature for 8 hours before terminating the reaction. The solvent was removed and the residue was separated by column chromatography to obtain 5-thiophen-1--1-en-2-yl diphenyl phosphate (137 mg, 80%) as a title compound.
1H NMR (300 MHz, CDCl3): δ 7.40-7.37 (m, 4H), 7.37-7.20 (m, 6H), 5.05 (t, J = 2.4 Hz, 1H), 4.72 (t, J = 2.4 Hz, 1H), 2.37 (t, J = 7.2 Hz, 2H), 2.31 (t, J = 7.1 Hz, 2H), 1.78 (q, J = 7.1 Hz, 2H)
1 H NMR (300 MHz, CDCl 3 ): δ 7.40-7.37 (m, 4H), 7.37-7.20 (m, 6H), 5.05 (t, J = 2.4 Hz, 1H), 4.72 (t, J = 2.4 Hz, 1H), 2.37 (t, J = 7.2 Hz, 2H), 2.31 (t, J = 7.1 Hz, 2H), 1.78 (q, J = 7.1 Hz, 2H)
[실시예 10] 5-(3,5-다이메틸페노시)펜트-1-엔-2-일 다이페닐 포스페이트(5-(3,5-Dimethylphenoxy)pent-1-en-2-yl diphenyl phosphate)의 제조Example 10 5- (3,5-dimethylphenoxy) pent-1-en-2-yl diphenyl phosphate (5- (3,5-Dimethylphenoxy) pent-1-en-2-yl diphenyl phosphate Manufacturing
V-바이알에 PPh3AuCl (12.4 mg, 0.025 mmol)과 AgPF6 (6.3 mg, 0.025 mmol)를 넣고 톨루엔 (2 mL)를 넣어 실온에서 교반시키고 여기에 다이페닐 포스페이트 (125 mg, 0.5 mmol)와 1,3-다이메틸-5-(펜트-4-이닐로시)벤젠 (123 mg, 0.6 mmol)을 차례로 첨가하여 80 ℃에서 8 시간 교반시킨 후 반응을 종결시켰다. 용매를 제거한 후 관 크로마토그래피로 분리하여, 표제화합물인 5-(3,5-다이메틸페노시)펜트-1-엔-2-일 다이페닐 포스페이트 (186.3 mg, 85 %) 를 얻었다.To a V-vial, add PPh 3 AuCl (12.4 mg, 0.025 mmol) and AgPF 6 (6.3 mg, 0.025 mmol), add toluene (2 mL) and stir at room temperature, add diphenyl phosphate (125 mg, 0.5 mmol) and 1,3-dimethyl-5- (pent-4-ynilocy) benzene (123 mg, 0.6 mmol) was added sequentially and stirred at 80 ° C. for 8 hours before terminating the reaction. After the solvent was removed, the residue was separated by column chromatography to obtain 5- (3,5-dimethylphenoxy) pent-1-en-2-yl diphenyl phosphate (186.3 mg, 85%) as a title compound.
1H NMR (400 MHz, CDCl3): δ 7.35 (t, J = 7.9 Hz, 4H), 7.26-7.18 (m, 6H), 6.59 ( s, 1H), 6.49 (s, 2H), 4.99 (t, J = 2.3 Hz, 1H), 4.66 (t, J = 2.2 Hz, 1H), 3.90 (t, J = 6.4 Hz, 2H), 2.41 (t, J = 7.5 Hz, 2H), 2.27 (s, 6H), 1.92 (qunt, J = 6.7 Hz, 2H)
1 H NMR (400 MHz, CDCl 3 ): δ 7.35 (t, J = 7.9 Hz, 4H), 7.26-7.18 (m, 6H), 6.59 (s, 1H), 6.49 (s, 2H), 4.99 (t, J = 2.3 Hz, 1H), 4.66 ( t, J = 2.2 Hz, 1H), 3.90 (t, J = 6.4 Hz, 2H), 2.41 (t, J = 7.5 Hz, 2H), 2.27 (s, 6H), 1.92 (qunt, J = 6.7 Hz, 2H)
[실시예 11] 1-페닐바이닐 다이페닐 포스페이트 (1-Phenylvinyl diphenyl phosphate)의 제조Example 11 Preparation of 1-Phenylvinyl diphenyl phosphate
V-바이알에 PPh3AuCl (12.4 mg, 0.025 mmol)과 AgPF6 (6.3 mg, 0.025 mmol)를 넣고 톨루엔 (2 mL)를 넣어 실온에서 교반시키고 여기에 다이페닐 포스페이트 (125 mg, 0.5 mmol)와 페닐아세틸렌 (61 mg, 0.6 mmol)을 차례로 첨가하여 60 ℃에서 12 시간 교반시킨 후 반응을 종결시켰다. 용매를 제거한 후 관 크로마토그래피로 분리하여, 표제화합물인 1-페닐-1-에텐-1-일 다이페닐 포스페이트 (155 mg, 88 %) 를 얻었다.To a V-vial, add PPh 3 AuCl (12.4 mg, 0.025 mmol) and AgPF 6 (6.3 mg, 0.025 mmol), add toluene (2 mL) and stir at room temperature, add diphenyl phosphate (125 mg, 0.5 mmol) and Phenylacetylene (61 mg, 0.6 mmol) was added sequentially and stirred at 60 ° C. for 12 hours before terminating the reaction. After the solvent was removed, the residue was separated by column chromatography to obtain 1-phenyl-1-ethen-1-yl diphenyl phosphate (155 mg, 88%) as a title compound.
1H NMR (400 MHz, CDCl3) δ 7.49-7.51 (m, 2H), 7.30-7.36 (m, 7H), 7.23-7.26 (m, 4H), 7.18-7.22 (m, 2H), 5.38 ( t, J = 2.9 Hz, 1H), 5.34 (t, J = 2.7 Hz, 1H)
1 H NMR (400 MHz, CDCl 3 ) δ 7.49-7.51 (m, 2H), 7.30-7.36 (m, 7H), 7.23-7.26 (m, 4H), 7.18-7.22 (m, 2H), 5.38 (t , J = 2.9 Hz, 1H), 5.34 (t, J = 2.7 Hz, 1H)
[실시예 12] 다이페닐 1-(4-트리플루오로메틸페닐)바이닐 다이페닐 포스페이트 (1-(4-Trifluoromethylphenyl)vinyl diphenyl phosphate)의 제조Example 12 Preparation of Diphenyl 1- (4-trifluoromethylphenyl) vinyl Diphenyl Phosphate (1- (4-Trifluoromethylphenyl) vinyl diphenyl phosphate)
V-바이알에 PPh3AuCl (12.4 mg, 0.025 mmol)과 AgPF6 (6.3 mg, 0.025 mmol)를 넣고 톨루엔 (2 mL)를 넣어 실온에서 교반시키고 여기에 다이페닐 포스페이트 (125 mg, 0.5 mmol)와 4-트리플루오로페닐아세틸렌 (102 mg, 0.6 mmol)을 차례로 첨가하여 60 ℃에서 17 시간 교반시킨 후 반응을 종결시켰다. 용매를 제거한 후 관 크로마토그래피로 분리하여, 표제화합물인 1-(4-트리플루오로메틸페닐)바이닐 다이페닐 포스페이트 (168 mg, 80 %) 를 얻었다.To a V-vial, add PPh 3 AuCl (12.4 mg, 0.025 mmol) and AgPF 6 (6.3 mg, 0.025 mmol), add toluene (2 mL) and stir at room temperature, add diphenyl phosphate (125 mg, 0.5 mmol) and 4-trifluorophenylacetylene (102 mg, 0.6 mmol) was added sequentially and stirred at 60 ° C. for 17 hours before terminating the reaction. After the solvent was removed, the residue was separated by column chromatography to obtain 1- (4-trifluoromethylphenyl) vinyl diphenyl phosphate (168 mg, 80%) as a title compound.
1H NMR (300 MHz, CDCl3) δ 7.57 (s, 4H), 7.39-7.34 (m, 4H), 7.26-7.20 (m, 6H), 5.49 (t, J = 3.0 Hz, 1H), 5.46 (t, J = 2.3 Hz, 1H)
1 H NMR (300 MHz, CDCl 3 ) δ 7.57 (s, 4H), 7.39-7.34 (m, 4H), 7.26-7.20 (m, 6H), 5.49 (t, J = 3.0 Hz, 1H), 5.46 ( t, J = 2.3 Hz, 1H)
[실시예 13] 1-(4-펜틸페닐)바이닐 다이페닐 포스페이트 (1-(4-Pentylphenyl)vinyl diphenyl phosphate)의 제조Example 13 Preparation of 1- (4-pentylphenyl) vinyl diphenyl phosphate (1- (4-Pentylphenyl) vinyl diphenyl phosphate)
V-바이알에 PPh3AuCl (12.4 mg, 0.025 mmol)과 AgPF6 (6.3 mg, 0.025 mmol)를 넣고 톨루엔 (2 mL)를 넣어 실온에서 교반시키고 여기에 다이페닐 포스페이트 (125 mg, 0.5 mmol)와 4-펜틸페닐아세틸렌 (103 mg, 0.6 mmol)을 차례로 첨가하여 60 ℃에서 8 시간 교반시킨 후 반응을 종결시켰다. 용매를 제거한 후 관 크로마토그래피로 분리하여, 표제화합물인 1-(4-펜틸페닐)바이닐 다이페닐 포스페이트 (201 mg, 95 %) 를 얻었다.To a V-vial, add PPh 3 AuCl (12.4 mg, 0.025 mmol) and AgPF 6 (6.3 mg, 0.025 mmol), add toluene (2 mL) and stir at room temperature, add diphenyl phosphate (125 mg, 0.5 mmol) and 4-pentylphenylacetylene (103 mg, 0.6 mmol) was added sequentially and stirred at 60 ° C. for 8 hours before terminating the reaction. After the solvent was removed, the residue was separated by column chromatography to obtain 1- (4-pentylphenyl) vinyl diphenyl phosphate (201 mg, 95%) as a title compound.
1H NMR (400 MHz, CDCl3) δ 7.40 (d, J = 8.3 Hz, 2H), 7.36-7.32 (m, 4H), 7.26-7.18 (m. 6H), 7.12 (d, J = 8.3 Hz, 2H), 5.33 (t, J = 2.9 Hz, 1H), 5.23 (t, J = 2.6 Hz, 1H), 2.59 (t, J = 7.7 Hz, 2H), 1.60 (quint, J = 7.6 Hz, 2H), 1.34-1.28 (m, 4H), 0.89 (t, J = 6.9, 3H)
1 H NMR (400 MHz, CDCl 3 ) δ 7.40 (d, J = 8.3 Hz, 2H), 7.36-7.32 (m, 4H), 7.26-7.18 (m. 6H), 7.12 (d , J = 8.3 Hz, 2H), 5.33 (t, J = 2.9 Hz, 1H), 5.23 (t, J = 2.6 Hz, 1H), 2.59 (t , J = 7.7 Hz, 2H), 1.60 (quint, J = 7.6 Hz, 2H) , 1.34-1.28 (m, 4H), 0.89 (t, J = 6.9, 3H)
[실시예 14] 1-(벤질티오)바이닐 다이페닐 포스페이트 (1-(Benzylthio)vinyl diphenyl phosphate)의 제조Example 14 Preparation of 1- (benzylthio) vinyl diphenyl phosphate (1- (Benzylthio) vinyl diphenyl phosphate)
V-바이알에 PPh3AuCl (12.4 mg, 0.025 mmol)과 AgPF6 (6.3 mg, 0.025 mmol)를 넣고 톨루엔 (2 mL)를 넣어 실온에서 교반시키고 여기에 다이페닐 포스페이트 (125 mg, 0.5 mmol)와 페닐 프로파질 티오이써 (90 mg, 0.6 mmol)을 차례로 첨가하여 실온에서 2 시간 교반시킨 후 반응을 종결시켰다. 용매를 제거한 후 관 크로마토그래피로 분리하여, 표제화합물인 1-(벤질타오)바이닐 다이페닐 포스페이트 (195 mg, 98 %) 를 얻었다.To a V-vial, add PPh 3 AuCl (12.4 mg, 0.025 mmol) and AgPF 6 (6.3 mg, 0.025 mmol), add toluene (2 mL) and stir at room temperature, add diphenyl phosphate (125 mg, 0.5 mmol) and Phenyl propazyl thioser (90 mg, 0.6 mmol) was added sequentially and stirred at room temperature for 2 hours before terminating the reaction. The solvent was removed and the residue was separated by column chromatography to obtain 1- (benzyltao) vinyl diphenyl phosphate (195 mg, 98%) as a title compound.
1H NMR (300 MHz, CDCl3) δ 7.39-7.34 (m, 4H), 7.29-7.19 (m, 11H), 5.26 (t, J = 2.6 Hz, 1H), 4.91 (t, J = 2.4 Hz, 1H), 3.90 (s, 2H)
1 H NMR (300 MHz, CDCl 3 ) δ 7.39-7.34 (m, 4H), 7.29-7.19 (m, 11H), 5.26 (t, J = 2.6 Hz, 1H), 4.91 (t, J = 2.4 Hz, 1H), 3.90 (s, 2H)
[실시예 15] (Z)-(2-(에톡시카보닐)바이닐) 다이페닐 포스페이트 ((Z)-(2-(Ethoxycarbonyl)vinyl) diphenyl phosphate)의 제조Example 15 Preparation of ( Z) -(2- (ethoxycarbonyl) vinyl) diphenyl phosphate (( Z) -(2- (Ethoxycarbonyl) vinyl) diphenyl phosphate)
V-바이알에 PPh3AuCl (12.4 mg, 0.025 mmol)과 AgPF6 (6.3 mg, 0.025 mmol)를 넣고 톨루엔 (2 mL)를 넣어 실온에서 교반시키고 여기에 다이페닐 포스페이트 (125 mg, 0.5 mmol)와 에틸 프로피올레이트 (59 mg, 0.6 mmol)을 차례로 첨가하여 실온에서 10 시간 교반시킨 후 반응을 종결시켰다. 용매를 제거한 후 관 크로마토그래피로 분리하여, 표제화합물인 Z-2-(에톡시카보닐)바이닐 다이페닐 포스페이트 (146 mg, 84 %) 를 얻었다.To a V-vial, add PPh 3 AuCl (12.4 mg, 0.025 mmol) and AgPF 6 (6.3 mg, 0.025 mmol), add toluene (2 mL) and stir at room temperature, add diphenyl phosphate (125 mg, 0.5 mmol) and Ethyl propiolate (59 mg, 0.6 mmol) was added sequentially and stirred at room temperature for 10 hours before terminating the reaction. After the solvent was removed, the residue was separated by column chromatography to obtain the title compound Z -2- (ethoxycarbonyl) vinyl diphenyl phosphate (146 mg, 84%).
1H NMR (400 MHz, CDCl3) δ 7.24-7.36 (m, 10H), 6.98 (t, J = 6.2 Hz, 1H), 5.31-5.33 (m, 1H), 4.18 (q, J = 7.34 Hz, 2H), 1.25 (t, J = 7.34 Hz, 3H)
1 H NMR (400 MHz, CDCl 3 ) δ 7.24-7.36 (m, 10H), 6.98 (t, J = 6.2 Hz, 1H), 5.31-5.33 (m, 1H), 4.18 (q, J = 7.34 Hz, 2H), 1.25 (t, J = 7.34 Hz, 3H)
[실시예 16] 에틸 (Z)-3-(다이페녹시포스포릴옥시)-3-페닐아크릴레이트 (Ethyl (Z)-3-(Diphenoxyphosphoryloxy)-3-phenylacrylate)의 제조Example 16 Preparation of ethyl ( Z ) -3- (diphenoxyphosphoryloxy) -3-phenylacrylate (Ethyl ( Z ) -3- (Diphenoxyphosphoryloxy) -3-phenylacrylate)
V-바이알에 PPh3AuCl (12.4 mg, 0.025 mmol)과 AgPF6 (6.3 mg, 0.025 mmol)를 넣고 톨루엔 (2 mL)를 넣어 실온에서 교반시키고 여기에 다이페닐 포스페이트 (125 mg, 0.5 mmol)와 페닐프로피오닉 엑시드 에틸 에스터 (104 mg, 0.6 mmol)을 차례로 첨가하여 60 ℃에서 10 시간 교반시킨 후 반응을 종결시켰다. 용매를 제거한 후 관 크로마토그래피로 분리하여, 표제화합물인 에틸 (Z)-3-(다이페녹시포스포릴옥시)-3-페닐아크릴레이트 (166 mg, 78 %) 를 얻었다.To a V-vial, add PPh 3 AuCl (12.4 mg, 0.025 mmol) and AgPF 6 (6.3 mg, 0.025 mmol), add toluene (2 mL) and stir at room temperature, add diphenyl phosphate (125 mg, 0.5 mmol) and Phenylpropionic acid ethyl ester (104 mg, 0.6 mmol) was added sequentially and stirred at 60 ° C. for 10 hours before terminating the reaction. After the solvent was removed, the residue was separated by column chromatography to obtain ethyl ( Z ) -3- (diphenoxyphosphoryloxy) -3-phenylacrylate (166 mg, 78%) as a title compound.
1H NMR (400 MHz, CDCl3) δ 7.12-7.65 (m, 15H), 6.11 (s, 1H), 4.18 (q, J = 7.3 Hz, 2H), 1.27 (t, J = 7.1 Hz, 3H)
1 H NMR (400 MHz, CDCl 3 ) δ 7.12-7.65 (m, 15H), 6.11 (s, 1H), 4.18 (q, J = 7.3 Hz, 2H), 1.27 (t, J = 7.1 Hz, 3H)
[실시예 17] (Z)-헥스-3-엔-3-일 다이페닐 포스페이트 ((Z)-Hex-3-en-3-yl diphenyl phosphate)의 제조Preparation of hex-3-en-3-yl-diphenyl phosphate ((Z) -Hex-3- en-3-yl diphenyl phosphate) - [ Example 17] (Z)
V-바이알에 PPh3AuCl (12.4 mg, 0.025 mmol)과 AgPF6 (6.3 mg, 0.025 mmol)를 넣고 톨루엔 (2 mL)를 넣어 실온에서 교반시키고 여기에 다이페닐 포스페이트 (125 mg, 0.5 mmol)와 3-헥신 (49 mg, 0.6 mmol)을 차례로 첨가하여 110 ℃에서 15 시간 교반시킨 후 반응을 종결시켰다. 용매를 제거한 후 관 크로마토그래피로 분리하여, 표제화합물인 에틸 (Z)-헥스-3-엔-3-일 다이페닐 포스페이트 (120 mg, 72 %) 를 얻었다.To a V-vial, add PPh 3 AuCl (12.4 mg, 0.025 mmol) and AgPF 6 (6.3 mg, 0.025 mmol), add toluene (2 mL) and stir at room temperature, add diphenyl phosphate (125 mg, 0.5 mmol) and 3-hexine (49 mg, 0.6 mmol) was added sequentially and stirred at 110 ° C. for 15 hours, after which the reaction was terminated. After the solvent was removed, the residue was separated by column chromatography to obtain ethyl ( Z) -hex-3-en-3-yl diphenyl phosphate (120 mg, 72%) as a title compound.
1H NMR (300 MHz, CDCl3) δ 7.38-7.30 (m, 4H), 7.27-7.17 (m, 6H), 4.87 (t, J = 7.3 Hz, 1H), 2.34 (q, J = 6.0 Hz, 2H), 2.05 (q, J = 7.5 Hz, 2H), 1.05 (t, J = 7.4 Hz, 3H), 0.88 (t, J = 7.5 Hz, 3H)
1 H NMR (300 MHz, CDCl 3 ) δ 7.38-7.30 (m, 4H), 7.27-7.17 (m, 6H), 4.87 (t, J = 7.3 Hz, 1H), 2.34 (q, J = 6.0 Hz, 2H), 2.05 (q, J = 7.5 Hz, 2H), 1.05 (t, J = 7.4 Hz, 3H), 0.88 (t, J = 7.5 Hz, 3H)
[실시예 18] (Z)-다이페닐-1-페닐프로프-1-엔-2-일 포스페이트 ((Z)-Diphenyl-1-phenylprop-1-en-2-yl phosphate)의 제조Preparation of diphenyl-1-phenyl-prop-1-en-2-yl phosphate ((Z) -Diphenyl-1- phenylprop-1-en-2-yl phosphate) - [ Example 18] (Z)
V-바이알에 PPh3AuCl (12.4 mg, 0.025 mmol)과 AgPF6 (6.3 mg, 0.025 mmol)를 넣고 톨루엔 (2 mL)를 넣어 실온에서 교반시키고 여기에 다이페닐 포스페이트 (125 mg, 0.5 mmol)와 1-페닐-1-프로핀 (70 mg, 0.6 mmol)을 차례로 첨가하여 110 ℃에서 10 시간 교반시킨 후 반응을 종결시켰다. 용매를 제거한 후 관 크로마토그래피로 분리하여, 표제화합물인 (Z)-다이페닐-1-페닐프로프-1-엔-2-일 포스페이트 (126 mg, 69 %) 를 얻었다.To a V-vial, add PPh 3 AuCl (12.4 mg, 0.025 mmol) and AgPF 6 (6.3 mg, 0.025 mmol), add toluene (2 mL) and stir at room temperature, add diphenyl phosphate (125 mg, 0.5 mmol) and 1-phenyl-1-propyne (70 mg, 0.6 mmol) was added sequentially and stirred at 110 ° C. for 10 hours before terminating the reaction. The solvent was removed and the residue was separated by column chromatography to obtain ( Z ) -diphenyl-1-phenylprop-1-en-2-yl phosphate (126 mg, 69%) as a title compound.
1H NMR (400 MHz, CDCl3) δ 7.39-7.37 (m, 2H), 7.32-7.28 (m, 4H), 7.22-7.16 (m, 9H), 5.76 (s, 1H), 2.29 (s, 3H)
1 H NMR (400 MHz, CDCl 3 ) δ 7.39-7.37 (m, 2H), 7.32-7.28 (m, 4H), 7.22-7.16 (m, 9H), 5.76 (s, 1H), 2.29 (s, 3H )
[실시예 19] 1-(3-(1-다이페녹시포스포릴옥시바이닐)페닐)바이닐 다이페닐 포스페이트 (1-(3-(1-Diphenoxyphosphoryloxyvinyl)phenyl)vinyl diphenyl phosphate)의 제조Example 19 Preparation of 1- (3- (1-diphenoxyphosphoryloxyvinyl) phenyl) vinyl diphenyl phosphate (1- (3- (1-Diphenoxyphosphoryloxyvinyl) phenyl) vinyl diphenyl phosphate)
V-바이알에 PPh3AuCl (12.4 mg, 0.025 mmol)과 AgPF6 (6.3 mg, 0.025 mmol)를 넣고 톨루엔 (2 mL)를 넣어 실온에서 교반시키고 여기에 다이페닐 포스페이트 (125 mg, 0.5 mmol)와 1,3-다이에티닐 벤젠 (75.7 mg, 0.6 mmol)을 차례로 첨가하여 110 ℃에서 5 시간 교반시킨 후 반응을 종결시켰다. 용매를 제거한 후 관 크로마토그래피로 분리하여, 표제화합물인 1-(3-(1-다이페녹시포스포릴옥시바이닐)페닐)바이닐 다이페닐 포스페이트 (303.87 mg, 97 %) 를 얻었다.To a V-vial, add PPh 3 AuCl (12.4 mg, 0.025 mmol) and AgPF 6 (6.3 mg, 0.025 mmol), add toluene (2 mL) and stir at room temperature, add diphenyl phosphate (125 mg, 0.5 mmol) and 1,3-diethynyl benzene (75.7 mg, 0.6 mmol) was added sequentially, stirred at 110 ° C. for 5 hours, and the reaction was terminated. The solvent was removed and the residue was separated by column chromatography to obtain 1- (3- (1-diphenoxyphosphoryloxyvinyl) phenyl) vinyl diphenyl phosphate (303.87 mg, 97%) as a title compound.
1H NMR (300 MHz, CDCl3) δ 7.62-7.36 (m, 10H), 7.25-7.17 (m, 14H), 5.35 (t, J = 1.6 Hz, 2H), 5.29 (t, J = 3.0 Hz, 2H)
1 H NMR (300 MHz, CDCl 3 ) δ 7.62-7.36 (m, 10H), 7.25-7.17 (m, 14H), 5.35 (t, J = 1.6 Hz, 2H), 5.29 (t, J = 3.0 Hz, 2H)
[실시예 20] 2-(다이페노시포릴로시)알릴 아세테이트 (2-(Diphenoxyphosphoryloxy)allyl acetate)의 제조Example 20 Preparation of 2- (Diphenoxyphosphoryloxy) allyl Acetate (2- (Diphenoxyphosphoryloxy) allyl acetate)
V-바이알에 PPh3AuCl (12.4 mg, 0.025 mmol)과 AgPF6 (6.3 mg, 0.025 mmol)를 넣고 톨루엔 (2 mL)를 넣어 실온에서 교반시키고 여기에 다이페닐 포스페이트 (125 mg, 0.5 mmol)와 프로파질 아세테이트 (58.9 mg, 0.6 mmol)을 차례로 첨가하여 80 ℃에서 8 시간 교반시킨 후 반응을 종결시켰다. 용매를 제거한 후 관 크로마토그래피로 분리하여, 표제화합물인 2-(다이페노시포릴로시)알릴 아세테이트 (88.8 mg, 51 %) 를 얻었다.To a V-vial, add PPh 3 AuCl (12.4 mg, 0.025 mmol) and AgPF 6 (6.3 mg, 0.025 mmol), add toluene (2 mL) and stir at room temperature, add diphenyl phosphate (125 mg, 0.5 mmol) and Propargyl acetate (58.9 mg, 0.6 mmol) was added sequentially and stirred at 80 ° C. for 8 hours before terminating the reaction. After the solvent was removed, the residue was separated by column chromatography to obtain 2- (diphenoxyphoryloxy) allyl acetate (88.8 mg, 51%) as a title compound.
1H NMR (300 MHz, CDCl3) δ 7.39-7.34 (m, 4H), 7.26-7.19 (m, 6H), 5.21 (t, J = 2.4 Hz, 1H), 4.93 (t, J = 2.4 Hz, 1H), 4.59 (s, 2H), 2.01 (s, 3H)
1 H NMR (300 MHz, CDCl 3 ) δ 7.39-7.34 (m, 4H), 7.26-7.19 (m, 6H), 5.21 (t, J = 2.4 Hz, 1H), 4.93 (t, J = 2.4 Hz, 1H), 4.59 (s, 2H), 2.01 (s, 3H)
[실시예 21] (E)-3-(다이페노시포스포릴로시)알릴아세테이트((E)-3-(Diphenoxyphosphoryloxy)allyl acetate)의 제조Preparation of [Example 21] (E) -3- (di-shi page phosphorylation reel City) allyl acetate ((E) -3- (Diphenoxyphosphoryloxy) allyl acetate)
V-바이알에 PPh3AuCl (12.4 mg, 0.025 mmol)과 AgPF6 (6.3 mg, 0.025 mmol)를 넣고 톨루엔 (2 mL)를 넣어 실온에서 교반시키고 여기에 다이페닐 포스페이트 (125 mg, 0.5 mmol)와 프로파질 아세테이트 (58.9 mg, 0.6 mmol)을 차례로 첨가하여 80 ℃에서 8 시간 교반시킨 후 반응을 종결시켰다. 용매를 제거한 후 관 크로마토그래피로 분리하여, 표제화합물인 2-(다이페노시포릴로시)알릴 아세테이트 (41.8 mg, 24 %) 를 얻었다.To a V-vial, add PPh 3 AuCl (12.4 mg, 0.025 mmol) and AgPF 6 (6.3 mg, 0.025 mmol), add toluene (2 mL) and stir at room temperature, add diphenyl phosphate (125 mg, 0.5 mmol) and Propargyl acetate (58.9 mg, 0.6 mmol) was added sequentially and stirred at 80 ° C. for 8 hours before terminating the reaction. After the solvent was removed, the residue was separated by column chromatography to obtain 2- (diphenoxyphoryloxy) allyl acetate (41.8 mg, 24%) as a title compound.
1H NMR (300 MHz, CDCl3) δ 7.39-7.34 (m, 4H), 7.26-7.19 (m, 6H), 6.72-6.68 (m, 1H), 5.19-5.16 (m, 1H), 4.65 (d, J = 7.0 Hz, 2H), 2.05 (s, 3H)
1 H NMR (300 MHz, CDCl 3 ) δ 7.39-7.34 (m, 4H), 7.26-7.19 (m, 6H), 6.72-6.68 (m, 1H), 5.19-5.16 (m, 1H), 4.65 (d , J = 7.0 Hz, 2H), 2.05 (s, 3H)
[실시예 22] (Z)-다이페닐-1-(페닐싸이오)옥트-1-엔-2-일 포스페이트((Z)-Diphenyl-1-(phenylthio)oct-1-en-2-yl phosphate)의 제조[Example 22] (Z) - diphenyl-1- (phenyl thio) oct-1-en-2-yl phosphate ((Z) -Diphenyl-1- ( phenylthio) oct-1-en-2-yl phosphate)
V-바이알에 PPh3AuCl (12.4 mg, 0.025 mmol)과 AgPF6 (6.3 mg, 0.025 mmol)를 넣고 톨루엔 (2 mL)를 넣어 실온에서 교반시키고 여기에 다이페닐 포스페이트 (125 mg, 0.5 mmol)와 옥트-1-이닐(페닐)설페인 (139.43 mg, 0.6 mmol)을 차례로 첨가하여 110 ℃에서 7 시간 교반시킨 후 반응을 종결시켰다. 용매를 제거한 후 관 크로마토그래피로 분리하여, 표제화합물인 (Z)-다이페닐-1-(페닐싸이오)옥트-1-엔-2-일 포스페이트 (153.4 mg, 80 %) 를 얻었다.To a V-vial, add PPh 3 AuCl (12.4 mg, 0.025 mmol) and AgPF 6 (6.3 mg, 0.025 mmol), add toluene (2 mL) and stir at room temperature, add diphenyl phosphate (125 mg, 0.5 mmol) and Oct-1-ynyl (phenyl) sulfane (139.43 mg, 0.6 mmol) was added sequentially and stirred at 110 ° C. for 7 hours before terminating the reaction. The solvent was removed and the residue was separated by column chromatography to obtain the title compound ( Z ) -diphenyl-1- (phenylthio) oct-1-en-2-yl phosphate (153.4 mg, 80%).
1H NMR (300 MHz, CDCl3) δ 7.37-7.27 (m, 10H), 7.24-7.08 (m, 5H), 5.71 (s, 1H), 1.52-1.43 (m, 2H), 1.33-1.24 (m, 8H), 0.86 (t, J = 6.6 Hz, 3H)
1 H NMR (300 MHz, CDCl 3 ) δ 7.37-7.27 (m, 10H), 7.24-7.08 (m, 5H), 5.71 (s, 1H), 1.52-1.43 (m, 2H), 1.33-1.24 (m , 8H), 0.86 (t, J = 6.6 Hz, 3H)
[실시예 23] 다이페닐-1-(페닐티오)옥트-1-에닐 포스페이트(Diphenyl 1-(phenylthio)oct-1-enyl phosphate)의 제조Example 23 Preparation of Diphenyl-1- (phenylthio) oct-1-enyl Phosphate (Diphenyl 1- (phenylthio) oct-1-enyl phosphate)
V-바이알에 PPh3AuCl (12.4 mg, 0.025 mmol)과 AgPF6 (6.3 mg, 0.025 mmol)를 넣고 톨루엔 (2 mL)를 넣어 실온에서 교반시키고 여기에 다이페닐 포스페이트 (125 mg, 0.5 mmol)와 옥트-1-이닐(페닐)설페인 (139.43 mg, 0.6 mmol)을 차례로 첨가하여 110 ℃에서 7 시간 교반시킨 후 반응을 종결시켰다. 용매를 제거한 후 관 크로마토그래피로 분리하여, 표제화합물인 다이페닐-1-(페닐티오)옥트-1-에닐 포스페이트 (42.2 mg, 18 %) 를 얻었다.To a V-vial, add PPh 3 AuCl (12.4 mg, 0.025 mmol) and AgPF 6 (6.3 mg, 0.025 mmol), add toluene (2 mL) and stir at room temperature, add diphenyl phosphate (125 mg, 0.5 mmol) and Oct-1-ynyl (phenyl) sulfane (139.43 mg, 0.6 mmol) was added sequentially and stirred at 110 ° C. for 7 hours before terminating the reaction. After the solvent was removed, the residue was separated by column chromatography to obtain the title compound diphenyl-1- (phenylthio) oct-1-enyl phosphate (42.2 mg, 18%).
1H NMR (300 MHz, CDCl3) isomer A δ 7.37-7.27 (m, 10H), 7.24-7.08 (m, 5H), 6.04 (t, J = 9.0 Hz, 1H), 2.31 (t, J = 10.1 Hz, 2H), 1.33-1.24 (m, 8H), 0.86 (t, J = 6.6 Hz, 3H). isomer B δ 7.37-7.27 (m, 10H), 7.24-7.08 (m, 5H), 5.79 (t, J = 7.5 Hz, 1H), 2.11 (t, J = 6.5 Hz, 2H), 1.33-1.24 (m, 8H), 0.86 (t, J = 6.6 Hz, 3H)
1 H NMR (300 MHz, CDCl 3 ) isomer A δ 7.37-7.27 (m, 10H), 7.24-7.08 (m, 5H), 6.04 (t, J = 9.0 Hz, 1H), 2.31 (t, J = 10.1 Hz, 2H), 1.33-1.24 (m, 8H), 0.86 (t, J = 6.6 Hz, 3H). isomer B δ 7.37-7.27 (m, 10H), 7.24-7.08 (m, 5H), 5.79 (t, J = 7.5 Hz, 1H), 2.11 (t, J = 6.5 Hz, 2H), 1.33-1.24 (m , 8H), 0.86 (t, J = 6.6 Hz, 3H)
[실시예 24] 1-(2-클로로페닐)바이닐 다이페닐 포스페이트 (1-(2-Chlorophenyl)vinyl diphenyl phosphate)의 제조Example 24 Preparation of 1- (2-Chlorophenyl) vinyl Diphenyl Phosphate (1- (2-Chlorophenyl) vinyl diphenyl phosphate)
V-바이알에 PPh3AuCl (12.4 mg, 0.025 mmol)과 AgPF6 (6.3 mg, 0.025 mmol)를 넣고 톨루엔 (2 mL)를 넣어 실온에서 교반시키고 여기에 다이페닐 포스페이트 (125 mg, 0.5 mmol)와 1-클로로-2-에티닐 벤젠(81.9 mg, 0.6 mmol)을 차례로 첨가하여 110 ℃에서 9 시간 교반시킨 후 반응을 종결시켰다. 용매를 제거한 후 관 크로마토그래피로 분리하여, 표제화합물인 1-(2-클로로페닐)바이닐 다이페닐 포스페이트 (54.1 mg, 28 %) 를 얻었다.To a V-vial, add PPh 3 AuCl (12.4 mg, 0.025 mmol) and AgPF 6 (6.3 mg, 0.025 mmol), add toluene (2 mL) and stir at room temperature, add diphenyl phosphate (125 mg, 0.5 mmol) and 1-chloro-2-ethynyl benzene (81.9 mg, 0.6 mmol) was added sequentially, stirred at 110 ° C. for 9 hours, and the reaction was terminated. After the solvent was removed, the residue was separated by column chromatography to obtain 1- (2-chlorophenyl) vinyl diphenyl phosphate (54.1 mg, 28%) as a title compound.
1H NMR (300 MHz, CDCl3) δ 7.43-7.37 (m, 2H), 7.35-7.27 (m, 5H), 7.23-7.16 (m, 7H), 5.52 (t, J = 2.5 Hz, 1H), 5.20 (t, J = 2.5 Hz, 1H)
1 H NMR (300 MHz, CDCl 3 ) δ 7.43-7.37 (m, 2H), 7.35-7.27 (m, 5H), 7.23-7.16 (m, 7H), 5.52 (t, J = 2.5 Hz, 1H), 5.20 (t, J = 2.5 Hz, 1H)
[실시예 25] (E)-2-클로로스티릴 다이페닐 포스페이트 ((E)-2-Chlorostyryl diphenyl phosphate)의 제조Example 25 Preparation of (E) -2-chlorostyryl diphenyl phosphate ((E) -2-Chlorostyryl diphenyl phosphate)
V-바이알에 PPh3AuCl (12.4 mg, 0.025 mmol)과 AgPF6 (6.3 mg, 0.025 mmol)를 넣고 톨루엔 (2 mL)를 넣어 실온에서 교반시키고 여기에 다이페닐 포스페이트 (125 mg, 0.5 mmol)와 1-클로로-2-에티닐 벤젠(81.9 mg, 0.6 mmol)을 차례로 첨가하여 110 ℃에서 9 시간 교반시킨 후 반응을 종결시켰다. 용매를 제거한 후 관 크로마토그래피로 분리하여, 표제화합물인 (E)-2-클로로스티릴 다이페닐 포스페이트 (131.5 mg, 68 %) 를 얻었다.To a V-vial, add PPh 3 AuCl (12.4 mg, 0.025 mmol) and AgPF 6 (6.3 mg, 0.025 mmol), add toluene (2 mL) and stir at room temperature, add diphenyl phosphate (125 mg, 0.5 mmol) and 1-chloro-2-ethynyl benzene (81.9 mg, 0.6 mmol) was added sequentially, stirred at 110 ° C. for 9 hours, and the reaction was terminated. After the solvent was removed, the residue was separated by column chromatography to obtain (E) -2-chlorostyryl diphenyl phosphate (131.5 mg, 68%) as a title compound.
1H NMR (300 MHz, CDCl3) δ 7.67 (d, J = 7.4 Hz, 1H), 7.40-7.32 (m, 5H), 7.24-7.09 (m, 8H), 6.87 (dd, J = 6.7 Hz, 1H), 6.17 (dd, J = 6.8 Hz, 1H)
1 H NMR (300 MHz, CDCl 3 ) δ 7.67 (d, J = 7.4 Hz, 1H), 7.40-7.32 (m, 5H), 7.24-7.09 (m, 8H), 6.87 (dd, J = 6.7 Hz, 1H), 6.17 (dd, J = 6.8 Hz, 1H)
[실시예 26] 1-(4-메톡시페닐)바이닐 다이페닐 포스페이트(1-(4-Methoxyphenyl)vinyl diphenyl phosphate)의 제조Example 26 Preparation of 1- (4-methoxyphenyl) vinyl diphenyl phosphate (1- (4-Methoxyphenyl) vinyl diphenyl phosphate)
V-바이알에 PPh3AuCl (12.4 mg, 0.025 mmol)과 AgPF6 (6.3 mg, 0.025 mmol)를 넣고 톨루엔 (2 mL)를 넣어 실온에서 교반시키고 여기에 다이페닐 포스페이트 (125 mg, 0.5 mmol)와 4-에티닐아니솔(79.3 mg, 0.6 mmol)을 차례로 첨가하여 실온에서 15 시간 교반시킨 후 반응을 종결시켰다. 용매를 제거한 후 관 크로마토그래피로 분리하여, 표제화합물인 1-(4-메톡시페닐)바이닐 다이페닐 포스페이트 (47.8 mg, 25 %) 를 얻었다.To a V-vial, add PPh 3 AuCl (12.4 mg, 0.025 mmol) and AgPF 6 (6.3 mg, 0.025 mmol), add toluene (2 mL) and stir at room temperature, add diphenyl phosphate (125 mg, 0.5 mmol) and 4-ethynylanisole (79.3 mg, 0.6 mmol) was added sequentially and stirred at room temperature for 15 hours before terminating the reaction. After the solvent was removed, the residue was separated by column chromatography to obtain 1- (4-methoxyphenyl) vinyl diphenyl phosphate (47.8 mg, 25%) as a title compound.
1H NMR (300 MHz, CDCl3) δ 7.43 (d, J = 11.9 Hz, 2H), 7.38-7.32 (m, 4H), 7.27-7.18 (m, 6H), 6.83 (d, J = 8.9 Hz, 2H), 5.26 (t, J = 2.9 Hz, 1H), 5.22 (t, J = 2.7 Hz, 1H), 3.81 (s, 3H)
1 H NMR (300 MHz, CDCl 3 ) δ 7.43 (d, J = 11.9 Hz, 2H), 7.38-7.32 (m, 4H), 7.27-7.18 (m, 6H), 6.83 (d, J = 8.9 Hz, 2H), 5.26 (t, J = 2.9 Hz, 1H), 5.22 (t, J = 2.7 Hz, 1H), 3.81 (s, 3H)
[실시예 27] 1-(다이페노시포스포리옥시)바이닐 페로센 (1-(Diphenoxyphosphoryloxy)vinyl ferrocene)의 제조Example 27 Preparation of 1- (Diphenoxyphosphoroxyoxy) vinyl Ferrocene (1- (Diphenoxyphosphoryloxy) vinyl ferrocene)
V-바이알에 PPh3AuCl (12.4 mg, 0.025 mmol)과 AgPF6 (6.3 mg, 0.025 mmol)를 넣고 톨루엔 (2 mL)를 넣어 실온에서 교반시키고 여기에 다이페닐 포스페이트 (125 mg, 0.5 mmol)와 에티닐페로센(126 mg, 0.6 mmol)을 차례로 첨가하여 실온에서 9 시간 교반시킨 후 반응을 종결시켰다. 용매를 제거한 후 관 크로마토그래피로 분리하여, 표제화합물인 1-(다이페노시포스포리옥시)바이닐 페로센 (140.6 mg, 55 %) 를 얻었다.To a V-vial, add PPh 3 AuCl (12.4 mg, 0.025 mmol) and AgPF 6 (6.3 mg, 0.025 mmol), add toluene (2 mL) and stir at room temperature, add diphenyl phosphate (125 mg, 0.5 mmol) and Ethynyl ferrocene (126 mg, 0.6 mmol) was added sequentially and stirred at room temperature for 9 hours, after which the reaction was terminated. The solvent was removed and the residue was separated by column chromatography to obtain 1- (diphenoxyphosphoroxyoxy) vinyl ferrocene (140.6 mg, 55%) as a title compound.
1H NMR (300 MHz, CDCl3) δ 7.43-7.31 (m, 8H), 7.24-7.22 (m, 2H), 5.12 (t, J = 2.4 Hz, 1H), 4.96 (t, J = 2.7 Hz, 1H), 4.35 (t, J = 1.9 Hz, 2H), 4.21 (t, J = 1.9 Hz, 2H), 4.08 (s, 5H)
1 H NMR (300 MHz, CDCl 3 ) δ 7.43-7.31 (m, 8H), 7.24-7.22 (m, 2H), 5.12 (t, J = 2.4 Hz, 1H), 4.96 (t, J = 2.7 Hz, 1H), 4.35 (t, J = 1.9 Hz, 2H), 4.21 (t, J = 1.9 Hz, 2H), 4.08 (s, 5H)
[실시예 28] 옥트-2-엔-2-일 다이페닐 포스페이트 (Oct-2-en-2-yl diphenyl phosphate)의 제조Example 28 Preparation of Oct-2-en-2-yl Diphenyl Phosphate
V-바이알에 (C6F5)3PAuCl (19.1 mg, 0.025 mmol)과 AgOTf (6.4 mg, 0.025 mmol)를 넣고 톨루엔 (2 mL)를 넣어 실온에서 교반시키고 여기에 다이페닐 포스페이트 (125 mg, 0.5 mmol)와 1-옥틴 (66 mg, 0.6 mmol)을 차례로 첨가하여 실온에서 24 시간 교반시킨 후 반응을 종결시켰다. 용매를 제거한 후 관 크로마토그래피로 분리하여, 표제화합물인 옥트-2-엔-2-일 다이페닐 포스페이트 (155 mg, 86 %) 를 얻었다.To a V-vial, add (C 6 F 5 ) 3 PAuCl (19.1 mg, 0.025 mmol) and AgOTf (6.4 mg, 0.025 mmol), add toluene (2 mL) at room temperature, and diphenyl phosphate (125 mg, 0.5 mmol) and 1-octin (66 mg, 0.6 mmol) were added sequentially and stirred at room temperature for 24 hours before terminating the reaction. After the solvent was removed, the residue was separated by column chromatography to obtain the title compound oct-2-en-2-yl diphenyl phosphate (155 mg, 86%).
1H NMR (300 MHz, CDCl3) δ 7.38-7.32 (m, 4H), 7.27-7.17 (m, 6H), 4.85 (t, J = 7.2 Hz, 1H), 2.02 (s, 3H), 1.97 (t, J = 7.2 Hz, 2H), 1.47-1.11 (m, 6H), 0.90-0.82 (m, 3H)
1 H NMR (300 MHz, CDCl 3 ) δ 7.38-7.32 (m, 4H), 7.27-7.17 (m, 6H), 4.85 (t, J = 7.2 Hz, 1H), 2.02 (s, 3H), 1.97 ( t, J = 7.2 Hz, 2H), 1.47-1.11 (m, 6H), 0.90-0.82 (m, 3H)
[실시예 29] 1-사이클로헥실프로프-1-엔-2-일 (1-Cyclohexylprop-1-en-2-yl diphenyl phosphate)의 제조Example 29 Preparation of 1-Cyclohexylprop-1-en-2-yl (1-Cyclohexylprop-1-en-2-yl diphenyl phosphate)
V-바이알에 (C6F5)3PAuCl (19.1 mg, 0.025 mmol)과 AgOTf (6.4 mg, 0.025 mmol)를 넣고 톨루엔 (2 mL)를 넣어 실온에서 교반시키고 여기에 다이페닐 포스페이트 (125 mg, 0.5 mmol)와 3-사이클로헥실-1-프로핀 (74 mg, 0.6 mmol)을 차례로 첨가하여 실온에서 24 시간 교반시킨 후 반응을 종결시켰다. 용매를 제거한 후 관 크로마토그래피로 분리하여, 표제화합물인 1-사이클로헥실프로프-1-엔-2-일 (173 mg, 93 %) 를 얻었다.To a V-vial, add (C 6 F 5 ) 3 PAuCl (19.1 mg, 0.025 mmol) and AgOTf (6.4 mg, 0.025 mmol), add toluene (2 mL) at room temperature, and diphenyl phosphate (125 mg, 0.5 mmol) and 3-cyclohexyl-1-propyne (74 mg, 0.6 mmol) were added sequentially and stirred at room temperature for 24 hours before terminating the reaction. After the solvent was removed, the residue was separated by column chromatography to obtain 1-cyclohexylprop-1-en-2-yl (173 mg, 93%) as a title compound.
1H NMR (300 MHz, CDCl3) δ 7.39-7.33 (m, 4H), 7.29-7.17 (m, 6H), 4.68 (d, J = 10.6 Hz, 1H), 2.01 (s, 3H), 1.72-1.56 (m, 6H), 1.29-0.88 (m, 5H)
1 H NMR (300 MHz, CDCl 3 ) δ 7.39-7.33 (m, 4H), 7.29-7.17 (m, 6H), 4.68 (d, J = 10.6 Hz, 1H), 2.01 (s, 3H), 1.72- 1.56 (m, 6H), 1.29-0.88 (m, 5H)
[실시예 30] 1-페닐프로프-1-엔-2-일 다이페닐 포스페이트 (1-Phenylprop-1-en-2-yl diphenyl phosphate)의 제조Example 30 Preparation of 1-phenylprop-1-en-2-yl diphenyl phosphate (1-Phenylprop-1-en-2-yl diphenyl phosphate)
V-바이알에 (C6F5)3PAuCl (19.1 mg, 0.025 mmol)과 AgOTf (6.4 mg, 0.025 mmol)를 넣고 톨루엔 (2 mL)를 넣어 실온에서 교반시키고 여기에 다이페닐 포스페이트 (125 mg, 0.5 mmol)와 3-페닐-1-프로핀 (70 mg, 0.6 mmol)을 차례로 첨가하여 실온에서 24 시간 교반시킨 후 반응을 종결시켰다. 용매를 제거한 후 관 크로마토그래피로 분리하여, 표제화합물인 1-페닐프로프-1-엔-2-일 다이페닐 포스페이트 (159 mg, 87 %) 를 얻었다.To a V-vial, add (C 6 F 5 ) 3 PAuCl (19.1 mg, 0.025 mmol) and AgOTf (6.4 mg, 0.025 mmol), add toluene (2 mL) at room temperature, and diphenyl phosphate (125 mg, 0.5 mmol) and 3-phenyl-1-propyne (70 mg, 0.6 mmol) were added sequentially and stirred at room temperature for 24 hours before terminating the reaction. After the solvent was removed, the residue was separated by column chromatography to obtain 1-phenylprop-1-en-2-yl diphenyl phosphate (159 mg, 87%) as a title compound.
1H NMR (300 MHz, CDCl3) δ 7.35-7.39 (m, 3H), 7.27-7.33 (m, 5H), 7.16-7.24 (m, 7H), 5.76 (s, 1H), 2.29 (s, 3H)
1 H NMR (300 MHz, CDCl 3 ) δ 7.35-7.39 (m, 3H), 7.27-7.33 (m, 5H), 7.16-7.24 (m, 7H), 5.76 (s, 1H), 2.29 (s, 3H )
[실시예 31] 다이페닐 5-페닐펜트-2-엔-2-일 포스페이트 (Diphenyl 5-phenylpent-2-en-2-yl phosphate)의 제조Example 31 Preparation of Diphenyl 5-phenylpent-2-en-2-yl phosphate
V-바이알에 (C6F5)3PAuCl (19.1 mg, 0.025 mmol)과 AgOTf (6.4 mg, 0.025 mmol)를 넣고 톨루엔 (2 mL)를 넣어 실온에서 교반시키고 여기에 다이페닐 포스페이트 (125 mg, 0.5 mmol)와 5-페닐-1-펜틴 (87 mg, 0.6 mmol)을 차례로 첨가하여 실온에서 24 시간 교반시킨 후 반응을 종결시켰다. 용매를 제거한 후 관 크로마토그래피로 분리하여, 표제화합물인 다이페닐 5-페닐펜트-2-엔-2-일 포스페이트 (168 mg, 85 %) 를 얻었다.To a V-vial, add (C 6 F 5 ) 3 PAuCl (19.1 mg, 0.025 mmol) and AgOTf (6.4 mg, 0.025 mmol), add toluene (2 mL) at room temperature, and diphenyl phosphate (125 mg, 0.5 mmol) and 5-phenyl-1-pentin (87 mg, 0.6 mmol) were added sequentially, stirred at room temperature for 24 hours, and the reaction was terminated. After the solvent was removed, the residue was separated by column chromatography to obtain the title compound diphenyl 5-phenylpent-2-en-2-yl phosphate (168 mg, 85%).
1H NMR (300 MHz, CDCl3) δ 7.37-7.28 (m, 4H), 7.26-7.10 (m, 10H), 7.09-7.07 (m, 1H), 4.88 (t, J = 7.2 Hz, 1H), 2.98 (t, J = 8.9 Hz, 2H), 2.37-2.24 (m, 2H), 2.02 (s, 3H)
1 H NMR (300 MHz, CDCl 3 ) δ 7.37-7.28 (m, 4H), 7.26-7.10 (m, 10H), 7.09-7.07 (m, 1H), 4.88 (t, J = 7.2 Hz, 1H), 2.98 (t, J = 8.9 Hz, 2H), 2.37-2.24 (m, 2H), 2.02 (s, 3H)
[실시예 32] 5-클로로펜트-2-엔-2-일 다이페닐 포스페이트 (5-Chloropent-2-en-2-yl diphenyl phosphate)의 제조Example 32 Preparation of 5-Chloropent-2-en-2-yl diphenyl phosphate
V-바이알에 (C6F5)3PAuCl (19.1 mg, 0.025 mmol)과 AgOTf (6.4 mg, 0.025 mmol)를 넣고 톨루엔 (2 mL)를 넣어 실온에서 교반시키고 여기에 다이페닐 포스페이트 (125 mg, 0.5 mmol)와 5-클로로-1-펜틴 (62 mg, 0.6 mmol)을 차례로 첨가하여 실온에서 24 시간 교반시킨 후 반응을 종결시켰다. 용매를 제거한 후 관 크로마토그래피로 분리하여, 표제화합물인 5-클로로펜트-2-엔-2-일 다이페닐 포스페이트 (155 mg, 86 %) 를 얻었다.To a V-vial, add (C 6 F 5 ) 3 PAuCl (19.1 mg, 0.025 mmol) and AgOTf (6.4 mg, 0.025 mmol), add toluene (2 mL) at room temperature, and diphenyl phosphate (125 mg, 0.5 mmol) and 5-chloro-1-pentin (62 mg, 0.6 mmol) were added sequentially and stirred at room temperature for 24 hours before terminating the reaction. After the solvent was removed, the residue was separated by column chromatography to obtain 5-chloropent-2-en-2-yl diphenyl phosphate (155 mg, 86%) as a title compound.
1H NMR (300 MHz, CDCl3) δ 7.34-7.40 (m, 4H), 7.19-7.27 (m, 6H), 4.97 (t, J = 7.3 Hz, 1H), 3.42 (t, J = 6.9 Hz, 2H), 2.39-2.47 (m, 2H), 2.05 (s, 3H) 1 H NMR (300 MHz, CDCl 3 ) δ 7.34-7.40 (m, 4H), 7.19-7.27 (m, 6H), 4.97 (t, J = 7.3 Hz, 1H), 3.42 (t, J = 6.9 Hz, 2H), 2.39-2.47 (m, 2H), 2.05 (s, 3H)
Claims (17)
[화학식 1]
[R1은 수소, (C1~C7)알킬, 할로(C1-C7)알킬, (C6-C20)아릴(C1-C7)알킬, (C6-C20)아릴티오, (C6-C20)아릴(C1-C7)알킬티오, (C1~C7)알킬옥시카보닐, (C6-C20)아릴, 할로(C6-C20)아릴, 페로세닐 또는 이며;
R2는 (R2 및 R3) 수소, (C1~C8)알킬, 할로(C1-C8)알킬, (C3-C7)사이클로알킬, (C1-C7)알콕시카보닐, (C6-C20)아릴티오, (C6-C20)아릴 또는 (C6-C20)아릴(C1-C8)알킬이고;
R3는 (C6-C20)아릴, (C1-C7)알킬 또는 (C6-C20)아릴(C1-C7)알킬이고;
상기 R1 및 R2의 알킬 및 아릴은 (C1-C7)알킬, 할로(C1-C7)알킬, (C1-C7)알콕시, (C1-C7)알킬카보닐옥시, (C6-C20)아릴(C1-C7)알킬옥시, 시아노, (C1-C7)알킬(C6-C20)아릴옥시 및 (C3-C7)사이클로알킬로 이루어진 군으로부터 선택되는 하나 이상으로 더 치환될 수 있다.]
Enol phosphate derivative represented by the following formula (1):
[Formula 1]
[R 1 is hydrogen, (C1-C7) alkyl, halo (C1-C7) alkyl, (C6-C20) aryl (C1-C7) alkyl, (C6-C20) arylthio, (C6-C20) aryl (C1 -C7) alkylthio, (C1-C7) alkyloxycarbonyl, (C6-C20) aryl, halo (C6-C20) aryl, ferrocenyl or Is;
R 2 is (R 2 And R 3 ) hydrogen, (C1-C8) alkyl, halo (C1-C8) alkyl, (C3-C7) cycloalkyl, (C1-C7) alkoxycarbonyl, (C6-C20) arylthio, (C6-C20 ) Aryl or (C6-C20) aryl (C1-C8) alkyl;
R 3 is (C6-C20) aryl, (C1-C7) alkyl or (C6-C20) aryl (C1-C7) alkyl;
Alkyl and aryl of R 1 and R 2 are (C 1 -C 7) alkyl, halo (C 1 -C 7) alkyl, (C 1 -C 7) alkoxy, (C 1 -C 7) alkylcarbonyloxy, (C 6 -C 20) aryl ( C1-C7) alkyloxy, cyano, (C1-C7) alkyl (C6-C20) aryloxy and (C3-C7) cycloalkyl may be further substituted with one or more selected.]
R1은 수소, 메틸, 에틸, 헥실, 벤질, 페닐프로필, 클로로메틸, 브로모메틸, 클로로에틸, 클로로프로필, 시아노프로필, 메틸카보닐옥시메틸, 벤질옥시프로필, 다이메틸페녹시프로필, 사이클로헥실메틸, 벤질티오, 페닐티오, 에톡시카보닐, 페닐, 펜틸페닐, 트리플루오로메틸페닐, 클로로페닐, 페로세닐, 메톡시페닐 또는 이며;
R2는 수소, 에틸, 펜틸, 헥실, 사이클로헥실, 페닐에틸, 클로로에틸, 에톡시카보닐, 페닐, 페닐티오, 메틸카보닐옥시메틸 또는 클로로페닐이고;
R3는 페닐, 메틸, 에틸, 프로필 또는 벤질인 것을 특징으로 하는 엔올 포스페이트 유도체.
The method of claim 1,
R 1 is hydrogen, methyl, ethyl, hexyl, benzyl, phenylpropyl, chloromethyl, bromomethyl, chloroethyl, chloropropyl, cyanopropyl, methylcarbonyloxymethyl, benzyloxypropyl, dimethylphenoxypropyl, cyclo Hexylmethyl, benzylthio, phenylthio, ethoxycarbonyl, phenyl, pentylphenyl, trifluoromethylphenyl, chlorophenyl, ferrocenyl, methoxyphenyl or Is;
R 2 is hydrogen, ethyl, pentyl, hexyl, cyclohexyl, phenylethyl, chloroethyl, ethoxycarbonyl, phenyl, phenylthio, methylcarbonyloxymethyl or chlorophenyl;
R 3 is enol phosphate derivative, characterized in that phenyl, methyl, ethyl, propyl or benzyl.
상기 엔올 포스페이트 유도체는 하기 구조로부터 선택되는 것을 특징으로 하는 엔올 포스페이트 유도체:
The method of claim 2,
The enol phosphate derivative is selected from the following structures:
하기 화학식 2로 표시되는 알카인 유도체와 화학식 4로 표시되는 포스페이트 유도체를 반응시켜 화학식 A의 카이네틱 엔올 포스페이트 유도체를 제조하는 것을 특징으로 하는 엔올 포스페이트 유도체의 제조방법.
[화학식 A]
[화학식 2]
[화학식 4]
[상기 식에서, R1은 수소, (C1~C7)알킬, 할로(C1-C7)알킬, (C6-C20)아릴(C1-C7)알킬, (C6-C20)아릴티오, (C6-C20)아릴(C1-C7)알킬티오, (C1~C7)알킬옥시카보닐, (C6-C20)아릴, 할로(C6-C20)아릴, 페로세닐 또는 이며;
R2는 수소, (C1~C7)알킬, (C1-C7)알콕시카보닐, (C6-C20)아릴티오 또는 (C6-C20)아릴이고;
R3는 (C6-C20)아릴, (C1-C7)알킬 또는 (C6-C20)아릴(C1-C7)알킬이고;
상기 R1 및 R2의 알킬 및 아릴은 (C1-C7)알킬, 할로(C1-C7)알킬, (C1-C7)알콕시, (C1-C7)알킬카보닐옥시, (C6-C20)아릴(C1-C7)알킬옥시, 시아노, (C1-C7)알킬(C6-C20)아릴옥시 및 (C3-C7)사이클로알킬로 이루어진 군으로부터 선택되는 하나 이상으로 더 치환될 수 있다.]
In the presence of a gold catalyst,
A method for preparing an enol phosphate derivative, which comprises producing a kinetic enol phosphate derivative of Formula A by reacting an alkane derivative represented by Formula 2 with a phosphate derivative represented by Formula 4.
[Formula A]
(2)
[Chemical Formula 4]
[Wherein, R 1 is hydrogen, (C1-C7) alkyl, halo (C1-C7) alkyl, (C6-C20) aryl (C1-C7) alkyl, (C6-C20) arylthio, (C6-C20) Aryl (C1-C7) alkylthio, (C1-C7) alkyloxycarbonyl, (C6-C20) aryl, halo (C6-C20) aryl, ferrocenyl or Is;
R 2 is hydrogen, (C1-C7) alkyl, (C1-C7) alkoxycarbonyl, (C6-C20) arylthio or (C6-C20) aryl;
R 3 is (C6-C20) aryl, (C1-C7) alkyl or (C6-C20) aryl (C1-C7) alkyl;
Alkyl and aryl of R 1 and R 2 are (C 1 -C 7) alkyl, halo (C 1 -C 7) alkyl, (C 1 -C 7) alkoxy, (C 1 -C 7) alkylcarbonyloxy, (C 6 -C 20) aryl ( C1-C7) alkyloxy, cyano, (C1-C7) alkyl (C6-C20) aryloxy and (C3-C7) cycloalkyl may be further substituted with one or more selected.]
하기 화학식 3으로 표시되는 알카인 유도체와 화학식 4로 표시되는 포스페이트 유도체를 반응시켜 화학식 B의 써모다이나믹 엔올 포스페이트 유도체를 제조하는 것을 특징으로 하는 엔올 포스페이트 유도체의 제조방법.
[화학식 B]
[화학식 3]
[화학식 4]
[상기 식에서, R2는 (C1~C7)알킬, 할로(C1-C7)알킬, (C3-C7)사이클로알킬, (C6-C20)아릴 또는 (C6-C20)아릴(C1-C7)알킬이고;
R3는 (C6-C20)아릴, (C1-C7)알킬 또는 (C6-C20)아릴(C1-C7)알킬이다.]
In the presence of a gold catalyst,
A method for preparing an enol phosphate derivative, which comprises preparing a thermodynamic enol phosphate derivative of Formula B by reacting an alkane derivative represented by Formula 3 with a phosphate derivative represented by Formula 4.
[Formula B]
(3)
[Chemical Formula 4]
[Wherein R 2 is (C 1 -C 7) alkyl, halo (C 1 -C 7) alkyl, (C 3 -C 7) cycloalkyl, (C 6 -C 20) aryl or (C 6 -C 20) aryl (C 1 -C 7) alkyl ;
R 3 is (C6-C20) aryl, (C1-C7) alkyl or (C6-C20) aryl (C1-C7) alkyl]
상기 금 촉매는 AuCl, AuCl3, AuBr3, PPh3AuCl, (C6F5)3PAuCl, (IPr)AuCl, (IMes)AuCl로 이루어지는 군으로부터 선택되는 1종 이상인 것을 특징으로 하는 제조방법.
The method according to claim 4 or 5,
The gold catalyst is AuCl, AuCl 3 , AuBr 3 , PPh 3 AuCl, (C 6 F 5 ) 3 PAuCl, (IPr) AuCl, (IMes) A production method characterized in that at least one selected from the group consisting of.
상기 금 촉매는 PPh3AuCl인 것을 특징으로 하는 제조방법.
The method of claim 4, wherein
The gold catalyst is characterized in that the PPh 3 AuCl.
상기 금 촉매는 (C6F5)3PAuCl인 것을 특징으로 하는 제조방법.
6. The method of claim 5,
The gold catalyst is characterized in that (C 6 F 5 ) 3 PAuCl.
상기 PPh3AuCl 촉매는 상기 화학식 4로 표시되는 포스페이트 유도체에 1 내지 10 mol%를 사용하는 것을 특징으로 하는 제조방법.
The method of claim 7, wherein
The PPh 3 AuCl catalyst is characterized in that 1 to 10 mol% is used for the phosphate derivative represented by the formula (4).
상기 (C6F5)3PAuCl 촉매는 상기 화학식 4로 표시되는 포스페이트 유도체에 1 내지 10 mol%를 사용하는 것을 특징으로 하는 제조방법.
The method of claim 8,
The (C 6 F 5 ) 3 PAuCl catalyst is characterized in that 1 to 10 mol% is used for the phosphate derivative represented by the formula (4).
상기 금 촉매 외에 AgOTf, AgBF4, AgPF6, AgAsF6, AgNTf2, AgSbF6 및 AgNO3로 이루어진 군에서 선택되는 은 촉매를 사용하는 것을 특징으로 하는 제조방법.
The method according to claim 4 or 5,
AgOTf, AgBF 4 , AgPF 6 , AgAsF 6 , AgNTf 2 , AgSbF 6 in addition to the gold catalyst And AgNO 3 , wherein the silver catalyst is selected from the group consisting of AgNO 3 .
상기 은 촉매의 사용량은 3가의 금 촉매를 사용하는 경우 금 촉매에 대해 2 내지 4 당량이고, 1가의 금 촉매를 사용하는 경우 동일 당량인 것을 특징으로 하는 제조방법.
12. The method of claim 11,
The use amount of the silver catalyst is 2 to 4 equivalents to the gold catalyst when using a trivalent gold catalyst, the production method characterized in that the same equivalent when using a monovalent gold catalyst.
상기 화학식 A로 표시되는 카이네틱 엔올 포스페이트의 제조시 AgPF6를 금 촉매와 더불어 사용하는 것을 특징으로 하는 제조방법.
The method of claim 4, wherein
A method for producing a kinetic enol phosphate represented by Formula A, wherein AgPF 6 is used together with a gold catalyst.
상기 화학식 B로 표시되는 써모다이나믹 엔올 포스페이트의 제조시 AgOTf를 금 촉매와 더불어 사용하는 것을 특징으로 하는 제조방법.
6. The method of claim 5,
In the preparation of the thermodynamic enol phosphate represented by the formula (B), AgOTf is used in combination with a gold catalyst.
상기 은 촉매는 금 촉매에 대해 1 내지 5 당량으로 사용하는 것을 특징으로 하는 제조방법.
The method according to claim 13 and 14,
The silver catalyst is a production method, characterized in that used in 1 to 5 equivalents to the gold catalyst.
상기 반응은 다이클로로메탄(DCM), 다이클로로에탄(DCE), 톨루엔(Toluene), 아세토나이트릴(MeCN), 나이트로메탄(Nitromethan), 테트라하이드로퓨란(THF), N,N-다이메틸포름아마이드(DMF), N,N-다이메틸아세트아마이드(DMA) 및 이들의 혼합물로부터 선택되는 용매 하에서 수행되는 것을 특징으로 하는 제조방법.
The method according to claim 4 or 5,
The reaction is dichloromethane (DCM), dichloroethane (DCE), toluene (Toluene), acetonitrile (MeCN), nitromethane (Nitromethan), tetrahydrofuran (THF), N, N -dimethylform A process characterized in that it is carried out under a solvent selected from amide (DMF), N, N -dimethylacetamide (DMA) and mixtures thereof.
상기 반응은 20 내지 140 ℃에서 톨루엔(Toluene)를 용매로 하여 상기 반응을 수행되는 것을 특징으로 하는 제조방법.The method according to claim 4 or 5,
The reaction is a manufacturing method characterized in that the reaction is carried out using toluene (Toluene) as a solvent at 20 to 140 ℃.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020100104367A KR101210428B1 (en) | 2010-10-26 | 2010-10-26 | Novel enol phosphate derivatives and their preparation method from alkynes catalyzed by gold |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020100104367A KR101210428B1 (en) | 2010-10-26 | 2010-10-26 | Novel enol phosphate derivatives and their preparation method from alkynes catalyzed by gold |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20120043191A true KR20120043191A (en) | 2012-05-04 |
KR101210428B1 KR101210428B1 (en) | 2012-12-10 |
Family
ID=46263422
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020100104367A KR101210428B1 (en) | 2010-10-26 | 2010-10-26 | Novel enol phosphate derivatives and their preparation method from alkynes catalyzed by gold |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101210428B1 (en) |
-
2010
- 2010-10-26 KR KR1020100104367A patent/KR101210428B1/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
KR101210428B1 (en) | 2012-12-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2378252C2 (en) | Novel method for synthesis of intermediate compounds, used in synthesis of vitamin d analogues | |
KR20060134045A (en) | Stereoselective synthesis of vitamin d analogues | |
KR100537324B1 (en) | Optically active bisoxazoline compounds, production and use thereof | |
KR101210428B1 (en) | Novel enol phosphate derivatives and their preparation method from alkynes catalyzed by gold | |
KR101606347B1 (en) | Novel 2-vinylphenyl phosphate derivatives and its preparation method | |
Rossi et al. | Stereocontrolled synthesis of carbon–carbon double bond locked analogues of strobilurins which are characterized by a trans-1, 2-disubstituted cyclopropane ring | |
Maleczka Jr et al. | Non-Pd transition metal-catalyzed hydrostannations: Bu3SnF/PMHS as a tin hydride source | |
CN101891731B (en) | Method for synthesizing olopatatadine E-configurational isomer | |
Yoshida et al. | Stereoselective synthesis of (Z)-β-fluoro-α, β-unsaturated esters from (Z)-2-fluoro-1-alkenyliodonium salts | |
CN104276946A (en) | Preparation method of juvenile hormone analogue | |
CN107522635B (en) | N-cyclopropyl nitrone derivatives and preparation method thereof | |
KR101140134B1 (en) | Novel 3-arylbutenolide derivatives and its preparation method | |
KR101220148B1 (en) | Novel pyrazole derivatives and its preparation method | |
US5189165A (en) | Process for the preparation of 1,1-disubstituted cyclopropane derivatives | |
KR20020019611A (en) | Process for the preparation of acylated 1,3-dicarbonyl compounds | |
CN104193656B (en) | A kind of beta-dicarbonyl sulfone compound and preparation method thereof | |
CN116003445A (en) | Alkyl zinc reagent and preparation method and application thereof | |
JP2004526741A (en) | Method for producing cyclopropane with enhanced chirality | |
JP4162891B2 (en) | Method for producing tetrahydrothiophene derivative | |
JP4591778B2 (en) | Process for producing α, β, γ-substituted cyclopentanone derivatives | |
Yoshikai | Enantioselective Conjugate Addition of | |
TW202316967A (en) | Process for preparing isoxazolinecarboxylic acid derivatives | |
KR101334026B1 (en) | Novel phosphorus 2-pyrone derivatives and its preparation method | |
KR101525491B1 (en) | Preparation method of benzoannulene derivatives by Using intramolecular Cycloreduction | |
JP4051967B2 (en) | Method for producing phosphonodihydropyran derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20151012 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20160927 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20181219 Year of fee payment: 7 |